| Year |
Citation |
Score |
| 2009 |
Basu S, Merino O. Global behavior of solutions to two classes of second-order rational difference equations Advances in Difference Equations. 2009. DOI: 10.1155/2009/128602 |
0.468 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2017 |
Basu S, Parghane RV. Designing and Developing PET-Based Precision Model in Thyroid Carcinoma: The Potential Avenues for a Personalized Clinical Care. Pet Clinics. 12: 27-37. PMID 27863564 DOI: 10.1016/j.cpet.2016.08.007 |
0.258 |
|
| 2008 |
Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Molecular Imaging and Biology. 10: 131-7. PMID 18297363 DOI: 10.1007/s11307-008-0134-7 |
0.257 |
|
| 2016 |
Basu S, Alavi A. PET-based Personalized Management in Clinical Oncology. An Unavoidable Path for the Foreseeable Future Pet Clinics. DOI: 10.1016/j.cpet.2016.03.002 |
0.252 |
|
| 2009 |
Basu S, Li G, Alavi A. PET and PET-CT imaging of gynecological malignancies: present role and future promise. Expert Review of Anticancer Therapy. 9: 75-96. PMID 19105709 DOI: 10.1586/14737140.9.1.75 |
0.251 |
|
| 2011 |
Basu S, Urhan M, Rosenbaum J, Alavi A. PET and PET/CT in the management of thyroid cancer. Methods in Molecular Biology (Clifton, N.J.). 727: 205-24. PMID 21331936 DOI: 10.1007/978-1-61779-062-1_12 |
0.251 |
|
| 2018 |
Thapa P, Kalshetty A, Basu S. F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary: A subgroup-specific analysis based on clinical presentation. World Journal of Nuclear Medicine. 17: 219-222. PMID 30505217 DOI: 10.4103/wjnm.WJNM_62_17 |
0.25 |
|
| 2012 |
Kumar Dhingra V, Kand P, Basu S. Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach. Women's Health (London, England). 8: 191-203. PMID 22375721 DOI: 10.2217/WHE.11.91 |
0.246 |
|
| 2012 |
Basu S, Saboury B, Torigian DA, Alavi A. Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment. Molecular Imaging and Biology. 13: 801-11. PMID 21136185 DOI: 10.1007/s11307-010-0426-6 |
0.246 |
|
| 2009 |
Basu S, Mohandas KM, Peshwe H, Asopa R, Vyawahare M. FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor. Nuclear Medicine Communications. 29: 1026-39. PMID 18987522 DOI: 10.1097/MNM.0b013e328313bbe7 |
0.245 |
|
| 2007 |
Basu S, Nair N, Banavali S. Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management. The British Journal of Radiology. 80: 750-6. PMID 17709361 DOI: 10.1259/BJR/53719785 |
0.245 |
|
| 2008 |
Basu S, Houseni M, Alavi A. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management. Nuclear Medicine Communications. 29: 367-73. PMID 18317302 DOI: 10.1097/MNM.0b013e3282f8147a |
0.245 |
|
| 2020 |
Kalshetty A, Basu S. Interpreting discordance on dual-tracer positron emission tomography-computed tomography in the setting of metastatic neuroendocrine tumor: Detection of metachronous triple-negative breast carcinoma. World Journal of Nuclear Medicine. 19: 414-416. PMID 33623512 DOI: 10.4103/wjnm.WJNM_15_20 |
0.244 |
|
| 2009 |
Basu S, Kumar R, Mavi A, Alavi A. Exploring Tumor Biology with Fluorodeoxyglucose-Positron Emission Tomography Imaging in Breast Carcinoma. Pet Clinics. 4: 381-9. PMID 27157307 DOI: 10.1016/j.cpet.2009.12.001 |
0.243 |
|
| 2010 |
Kwee TC, Basu S, Cheng G, Alavi A. FDG PET/CT in carcinoma of unknown primary European Journal of Nuclear Medicine and Molecular Imaging. 37: 635-644. PMID 19882152 DOI: 10.1007/s00259-009-1295-6 |
0.243 |
|
| 2020 |
Sharma P, Basu S. Poorly differentiated Neuroendocrine carcinoma (small cell) of Parotid Gland and 'Moderately differentiated' Hepatic metastases: a Discordant Histopathology clarified by dual tracer PET-CT (Ga-DOTATATE and F-FDG) for predicting tumor biology and treatment decision-making. Journal of Nuclear Medicine Technology. PMID 33020231 DOI: 10.2967/jnmt.120.251587 |
0.243 |
|
| 2011 |
Basu S, Kwee TC, Surti S, Akin EA, Yoo D, Alavi A. Fundamentals of PET and PET/CT imaging. Annals of the New York Academy of Sciences. 1228: 1-18. PMID 21718318 DOI: 10.1111/J.1749-6632.2011.06077.X |
0.242 |
|
| 2010 |
Basu S, Kwee TC, Alavi A. PET and PET/CT Assessment of Gynecologic Malignancies: Beyond FDG. Pet Clinics. 5: 477-82. PMID 27157974 DOI: 10.1016/j.cpet.2010.07.006 |
0.242 |
|
| 2007 |
Basu S, Nair N, Shet T. Detection of unsuspected metachronous second primary malignancy giving rise to supposed "non-iodine avid metastasis" in differentiated thyroid carcinoma. Clinical Nuclear Medicine. 32: 655-8. PMID 17667446 DOI: 10.1097/RLU.0B013E3180A1AC5C |
0.241 |
|
| 2011 |
Kwee TC, Basu S, Alavi A. PET and PET/CT for unknown primary tumors Methods in Molecular Biology (Clifton, N.J.). 727: 317-333. PMID 21331941 DOI: 10.1007/978-1-61779-062-1_17 |
0.241 |
|
| 2015 |
Basu S, Goliwale F. Aggressive Clinical Course of Dermatofibrosarcoma protuberans: 18F-FDG PET-CT predictive of Tumor Biology. Journal of Nuclear Medicine Technology. PMID 26338485 DOI: 10.2967/jnmt.115.163212 |
0.241 |
|
| 2009 |
Basu S, Li G, Bural G, Alavi A. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Acta Radiologica (Stockholm, Sweden : 1987). 50: 201-4. PMID 19089692 DOI: 10.1080/02841850802620689 |
0.241 |
|
| 2011 |
Kwee TC, Basu S, Saboury B, Ambrosini V, Torigian DA, Alavi A. A new dimension of FDG-PET interpretation: Assessment of tumor biology European Journal of Nuclear Medicine and Molecular Imaging. 38: 1158-1170. PMID 21225422 DOI: 10.1007/s00259-010-1713-9 |
0.241 |
|
| 2008 |
Mavi A, Dhuriraj T, Cermik TF, Urhan M, Wasik M, Basu S, Kumar R, Torigian D, Alavi A. Central photopenic lesions on FDG-PET scan in a patient with peripheral T cell lymphoma. Annals of Nuclear Medicine. 22: 629-33. PMID 18756366 DOI: 10.1007/s12149-008-0164-x |
0.24 |
|
| 2017 |
Sampathirao N, Basu S. Mib1 index stratified assessment of Dual Tracer PET-CT with 68Ga-DOTATATE and 18F-FDG and multimodality anatomical imaging in Metastatic NET of Unknown Primary (CUP-NET) scheduled for PRRT. Journal of Nuclear Medicine Technology. PMID 28154019 DOI: 10.2967/jnmt.116.185777 |
0.24 |
|
| 2011 |
Basu S, Zaidi H, Holm S, Alavi A. Quantitative Techniques in PET-CT Imaging Current Medical Imaging Reviews. 7: 216-233. DOI: 10.2174/157340511796411186 |
0.24 |
|
| 2010 |
Basu S, Baghel NS, Puri A, Shet T, Merchant NH. 18 F-FDG avid lesion due to coexistent fibrous dysplasia in a child of embryonal rhabdomyosarcoma: source of false positive FDG-PET. Journal of Cancer Research and Therapeutics. 6: 92-4. PMID 20479556 DOI: 10.4103/0973-1482.63564 |
0.24 |
|
| 2021 |
Loharkar S, Basu S. Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging (F-fluorodeoxyglucose and Ga-DOTATATE) correlates and their treatment implications. World Journal of Nuclear Medicine. 20: 125-128. PMID 33850504 DOI: 10.4103/wjnm.WJNM_67_20 |
0.24 |
|
| 2012 |
Vural GU, Akkas BE, Ercakmak N, Basu S, Alavi A. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data. Clinical Nuclear Medicine. 37: 953-9. PMID 22899202 DOI: 10.1097/RLU.0b013e31825b2057 |
0.239 |
|
| 2008 |
Kumar R, Basu S, Torigian D, Anand V, Zhuang H, Alavi A. Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clinical Microbiology Reviews. 21: 209-24. PMID 18202443 DOI: 10.1128/CMR.00025-07 |
0.239 |
|
| 2019 |
Parghane RV, Talole S, Basu S. Prevalence of hitherto unknown brain meningioma detected on Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors. World Journal of Nuclear Medicine. 18: 160-170. PMID 31040748 DOI: 10.4103/wjnm.WJNM_39_18 |
0.238 |
|
| 2012 |
Basu S, Saboury B, Werner T, Alavi A. Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders. Molecular Imaging and Biology. 13: 1051-60. PMID 21161689 DOI: 10.1007/s11307-010-0459-x |
0.238 |
|
| 2009 |
Mavi A, Basu S, Cermik TF, Urhan M, Bathaii M, Thiruvenkatasamy D, Houseni M, Dadparvar S, Alavi A. Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease. Molecular Imaging and Biology. 11: 369-78. PMID 19472014 DOI: 10.1007/s11307-009-0212-5 |
0.237 |
|
| 2007 |
Basu S, Mahne A, Iruvuri S, Alavi A. Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland Clinical Lymphoma and Myeloma. 7: 309-314. PMID 17324340 DOI: 10.3816/CLM.2007.n.008 |
0.237 |
|
| 2014 |
Shejul Y, Chhajed PN, Basu S. 18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement. Journal of Nuclear Medicine Technology. 42: 235-7. PMID 24948823 DOI: 10.2967/jnmt.113.132985 |
0.237 |
|
| 2018 |
Parghane RV, Basu S. PET/Computed Tomography and PET/MR Imaging: Basic Principles, Methodology, and Imaging Protocol for Musculoskeletal Applications. Pet Clinics. 13: 459-476. PMID 30219182 DOI: 10.1016/j.cpet.2018.05.003 |
0.236 |
|
| 2012 |
Basu S, Zhuang H, Alavi A. FDG PET and PET/CT Imaging in Complicated Diabetic Foot. Pet Clinics. 7: 151-60. PMID 27157233 DOI: 10.1016/j.cpet.2012.01.003 |
0.236 |
|
| 2010 |
Tiwari BP, Jangra S, Nair N, Tongaonkar HB, Basu S. Complimentary role of FDG-PET imaging and skeletal scintigraphy in the evaluation of patients of prostate carcinoma. Indian Journal of Cancer. 47: 385-90. PMID 21131750 DOI: 10.4103/0019-509X.73572 |
0.235 |
|
| 2010 |
Basu S, Asopa RV, Baghel NS. Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG-PET. Clinical Nuclear Medicine. 34: 689-90. PMID 19893402 DOI: 10.1097/RLU.0b013e3181b53155 |
0.235 |
|
| 2009 |
Basu S, Tiwari BP. Asymmetric 18F-FDG uptake in the infradiaphragmatic brown adipose tissue (BAT) mimicking adrenal metastasis: A relatively rare site of brown fat and a potential source for false positive FDG-PET study Journal of Radiology Case Reports. 3: 19-22. DOI: 10.3941/jrcr.v3i10.314 |
0.234 |
|
| 2015 |
Kumar NS, Barve K, Joshi J, Basu S. Low grade FDG uptake on the rim of "doughnut" in PET-CT in an asymptomatic Hydatid cyst: is inflammatory activity a determinant of symptoms? Journal of Nuclear Medicine Technology. PMID 26111709 DOI: 10.2967/jnmt.115.155408 |
0.234 |
|
| 2015 |
Targe M, Basu S. Focal thyroid incidentaloma on whole body fluorodeoxyglucose positron emission tomography/computed tomography in known cancer patients: A case-based discussion with a series of three examples. Journal of Cancer Research and Therapeutics. 11: 1029. PMID 26881609 DOI: 10.4103/0973-1482.154029 |
0.234 |
|
| 2018 |
Kalshetty A, Basu S. Non-F-2-Fluoro-2-Deoxy-d-Glucose PET/Computed Tomography in Gynecologic Oncology: An Overview of Current Status and Future Potential. Pet Clinics. 13: 239-248. PMID 29482752 DOI: 10.1016/j.cpet.2017.11.008 |
0.232 |
|
| 2014 |
Basu S, Hess S, Nielsen Braad PE, Olsen BB, Inglev S, Høilund-Carlsen PF. The Basic Principles of FDG-PET/CT Imaging. Pet Clinics. 9: 355-70, v. PMID 26050942 DOI: 10.1016/j.cpet.2014.07.006 |
0.232 |
|
| 2018 |
Chakraborty D, Basu S, Ulaner GA, Alavi A, Kumar R. Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current Application. Pet Clinics. 13: 355-361. PMID 30100075 DOI: 10.1016/j.cpet.2018.02.011 |
0.232 |
|
| 2011 |
Carey K, Saboury B, Basu S, Brothers A, Ogdie A, Werner T, Torigian DA, Alavi A. Evolving role of FDG PET imaging in assessing joint disorders: a systematic review. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1939-55. PMID 21755370 DOI: 10.1007/s00259-011-1863-4 |
0.232 |
|
| 2011 |
Basu S, Kumar R, Alavi A. PET and PET-CT imaging in infection and inflammation: its critical role in assessing complications related to therapeutic interventions in patients with cancer. Indian Journal of Cancer. 47: 371-9. PMID 21131748 DOI: 10.4103/0019-509X.73562 |
0.231 |
|
| 2012 |
Urhan M, Basu S, Alavi A. PET Scan in Thyroid Cancer. Pet Clinics. 7: 453-61. PMID 27157651 DOI: 10.1016/j.cpet.2012.06.008 |
0.231 |
|
| 2010 |
Basu S, Rao R. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 165; author reply 16. PMID 20008984 DOI: 10.2967/jnumed.109.066860 |
0.23 |
|
| 2012 |
Basu S, Shah M, Joshi JM, Lad S. Imaging calcific concretions of pulmonary alveolar microlithiasis with PET: insight into disease pathophysiology. Clinical Nuclear Medicine. 37: 707-8. PMID 22691522 DOI: 10.1097/RLU.0b013e318251dfd0 |
0.23 |
|
| 2014 |
Saboury B, Salavati A, Brothers A, Basu S, Kwee TC, Lam MG, Hustinx R, Louis E, Torigian DA, Alavi A. FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity. European Journal of Nuclear Medicine and Molecular Imaging. 41: 605-14. PMID 24253895 DOI: 10.1007/s00259-013-2625-2 |
0.229 |
|
| 2017 |
Parghane RV, Basu S. Dual-time point (18)F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations. Seminars in Nuclear Medicine. 47: 373-391. PMID 28583277 DOI: 10.1053/j.semnuclmed.2017.02.009 |
0.228 |
|
| 2007 |
Basu S, Nair N. Intense F-18 FDG uptake in the stomach wall in follicular gastritis in Zollinger-Ellison syndrome Clinical Nuclear Medicine. 32: 150-151. PMID 17242575 DOI: 10.1097/01.rlu.0000251951.46386.d6 |
0.228 |
|
| 2015 |
Basu S, Kumar NS, Joshi J. Findings on early treatment response assessment with 18F-FDG PET/CT as a pointer toward a 'second-look' at the diagnosis: an ancillary observation but with potential implications for patient management in a multidisciplinary setting. Nuclear Medicine Communications. 36: 653-4. PMID 25759943 DOI: 10.1097/MNM.0000000000000304 |
0.228 |
|
| 2012 |
Basu S, Baghel NS. Value of delayed PET imaging in mucinous adenocarcinoma rectum: should this be employed while evaluating mucinous tumors with FDG-PET? Indian Journal of Cancer. 48: 374-5. PMID 21921347 DOI: 10.4103/0019-509X.84923 |
0.228 |
|
| 2006 |
Basu S, Nair N. "Cold" vertebrae on F-18 FDG PET: Causes and characteristics Clinical Nuclear Medicine. 31: 445-450. PMID 16855427 DOI: 10.1097/01.rlu.0000227011.21544.19 |
0.227 |
|
| 2012 |
Basu S, Kembhavi S. Serendipitous observation of hepatic metastases on (18)F-fluoride PET in a patient with infiltrating ductal carcinoma of breast: correlation with contrast enhanced CT. Clinical Nuclear Medicine. 37: 1176-8. PMID 23154477 DOI: 10.1097/RLU.0b013e318270820a |
0.226 |
|
| 2016 |
Basu S, Ranade R, Ostwal V, Shrikhande SV. PET-Based Molecular Imaging in Designing Personalized Management Strategy in Gastroenteropancreatic Neuroendocrine Tumors Pet Clinics. DOI: 10.1016/j.cpet.2016.02.004 |
0.226 |
|
| 2020 |
Adnan A, Basu S. Gratifying results with combined Chemo-PRRT (Lu-DOTATATE and platinum-based chemotherapy) in Recurrent Metastatic Sinonasal Neuroendocrine Carcinoma with high uptake on both Ga-DOTATATE and F-FDG PET-CT: a Promising Therapeutic Option. Journal of Nuclear Medicine Technology. PMID 32358042 DOI: 10.2967/jnmt.119.237354 |
0.226 |
|
| 2013 |
Basu S, Abhyankar A. The added clinical value of 18F-FDG PET/CT in evaluating intratracheal recurrence of differentiated thyroid carcinoma: implications for planning surgery, assessing its completeness, and planning radioiodine therapy. Journal of Nuclear Medicine Technology. 41: 302-5. PMID 24159010 DOI: 10.2967/jnmt.113.127910 |
0.225 |
|
| 2015 |
Dhingra VK, Mahajan A, Basu S. Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care. The Indian Journal of Radiology & Imaging. 25: 332-41. PMID 26752813 DOI: 10.4103/0971-3026.169467 |
0.224 |
|
| 2014 |
Basu S, Abhyankar A. The use of 99mTc-HYNIC-TOC and 18F-FDG PET/CT in the evaluation of duodenal neuroendocrine tumor with atypical and extensive metastasis responding dramatically to a single fraction of PRRT with 177Lu-DOTATATE. Journal of Nuclear Medicine Technology. 42: 296-8. PMID 25190735 DOI: 10.2967/jnmt.114.139238 |
0.224 |
|
| 2012 |
Saboury B, Ziai P, Parsons M, Zhuang H, Basu S, Alavi A. Promising Roles of PET in Management of Arthroplasty-Associated Infection. Pet Clinics. 7: 139-50. PMID 27157232 DOI: 10.1016/j.cpet.2012.01.002 |
0.224 |
|
| 2019 |
Adnan A, Sampathirao N, Basu S. Implications of fluorodeoxyglucose uptake in low-intermediate grade metastatic neuroendocrine tumors from peptide receptor radionuclide therapy outcome viewpoint: A semi-quantitative standardized uptake value-based analysis. World Journal of Nuclear Medicine. 18: 389-395. PMID 31933555 DOI: 10.4103/wjnm.WJNM_62_18 |
0.223 |
|
| 2010 |
Basu S. PET and PET/CT in gastrointestinal stromal tumours: the unanswered questions and the potential newer applications. European Journal of Nuclear Medicine and Molecular Imaging. 37: 1255-8. PMID 20238112 DOI: 10.1007/s00259-010-1404-6 |
0.223 |
|
| 2012 |
Vijayant V, Sarma M, Aurangabadkar H, Bichile L, Basu S. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies. World Journal of Radiology. 4: 462-8. PMID 23320137 DOI: 10.4329/wjr.v4.i12.462 |
0.222 |
|
| 2007 |
Basu S, Zaidi H, Alavi A. New Concepts for Assessing Global Organ Function and Disease Activity Based on Combined PET and Structural Imaging Techniques. Pet Clinics. 2: 279-87. PMID 27157878 DOI: 10.1016/j.cpet.2007.10.001 |
0.222 |
|
| 2016 |
Basu S, Mahajan A, Arya S. Multimodality Molecular Imaging (FDG-PET/CT, US Elastography, and DWI-MRI) as Complimentary Adjunct for Enhancing Diagnostic Confidence in Reported Intermediate Risk Category Thyroid Nodules on Bethesda Thyroid Cytopathology Reporting System. World Journal of Nuclear Medicine. 15: 130-3. PMID 27134564 DOI: 10.4103/1450-1147.176883 |
0.222 |
|
| 2016 |
Basu S, Utpat K, Joshi J. 18F-FDG-PET/CT imaging features at initial diagnosis and in the context of early treatment monitoring in IgG4 related Pulmonary Inflammatory Pseudotumor. Journal of Nuclear Medicine Technology. PMID 26848165 DOI: 10.2967/jnmt.115.168450 |
0.222 |
|
| 2005 |
Basu S, Nair N. (18)FDG PET in primary oat cell carcinoma of the esophagus Indian Journal of Cancer. 42: 60-62. PMID 15805695 DOI: 10.4103/0019-509X.15103 |
0.221 |
|
| 2018 |
Parghane RV, Basu S. Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual Tracer PET/CT (Ga-PSMA and F-FDG): Potential Clinical Utility in Therapeutic Decision-Making and Treatment Monitoring. Journal of Nuclear Medicine Technology. PMID 30139889 DOI: 10.2967/jnmt.118.215582 |
0.219 |
|
| 2009 |
Bahl S, Alavi A, Basu S, Kumar R, Czerniecki BJ. The Role of PET and PET/CT in the Surgical Management of Breast Cancer: A Review. Pet Clinics. 4: 277-87. PMID 27157100 DOI: 10.1016/j.cpet.2009.10.002 |
0.219 |
|
| 2016 |
Hess S, Alavi A, Basu S. PET-Based Personalized Management of Infectious and Inflammatory Disorders Pet Clinics. DOI: 10.1016/j.cpet.2016.02.008 |
0.219 |
|
| 2008 |
Fisher MJ, Basu S, Dombi E, Yu JQ, Widemann BC, Pollock AN, Cnaan A, Zhuang H, Phillips PC, Alavi A. The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression. Journal of Neuro-Oncology. 87: 165-71. PMID 18071635 DOI: 10.1007/s11060-007-9501-5 |
0.219 |
|
| 2013 |
Sharma P, Singh H, Basu S, Kumar R. Positron emission tomography-computed tomography in the management of lung cancer: An update. South Asian Journal of Cancer. 2: 171-8. PMID 24455612 DOI: 10.4103/2278-330X.114148 |
0.218 |
|
| 2014 |
Basu S, Yadav M, Joshi J. Potential of 18F-FDG-PET and PET/CT in nonmalignant pulmonary disorders: much more than currently perceived? Making the case from experience gained in the Indian scenario. Nuclear Medicine Communications. 35: 689-96. PMID 24736327 DOI: 10.1097/MNM.0000000000000127 |
0.218 |
|
| 2007 |
Basu S, Alavi A. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging. Clinical Nuclear Medicine. 32: 388-9. PMID 17452870 DOI: 10.1097/01.RLU.0000259613.28127.F8 |
0.217 |
|
| 2011 |
Basu S, Jambhekar NA. Primary malignant melanoma presenting as FDG avid large necrotic splenic mass with metastatic retroperitoneal adenopathy: FDG-PET and histopathological correlation. Journal of Cancer Research and Therapeutics. 7: 96-7. PMID 21546755 DOI: 10.4103/0973-1482.80451 |
0.217 |
|
| 2008 |
Alavi A, Basu S. Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time? European Journal of Nuclear Medicine and Molecular Imaging. 35: 1554-9. PMID 18594816 DOI: 10.1007/s00259-008-0813-2 |
0.217 |
|
| 2010 |
Basu S, Alavi A. Molecular imaging (PET) of brain tumors. Neuroimaging Clinics of North America. 19: 625-46. PMID 19959009 DOI: 10.1016/j.nic.2009.08.012 |
0.217 |
|
| 2016 |
Basu S, Ranade R. Metachronous second primary of the oesophagus detected by FDG-PET/CT in a patient with follicular variant of papillary thyroid carcinoma. The National Medical Journal of India. 29: 36. PMID 27492039 DOI: 10.4103/0970-258X.186920 |
0.216 |
|
| 2013 |
Basu S, Kembhavi S. Unusual isolated perineal recurrence in mucinous adenocarcinoma of the rectum after abdominoperineal resection: usefulness of dual-time-point FDG PET in evaluating mucinous tumors. Clinical Nuclear Medicine. 37: 989-90. PMID 22955074 DOI: 10.1097/RLU.0b013e3182639024 |
0.216 |
|
| 2017 |
Bansal S, Utpat K, Desai U, Basu S, Joshi JM. Sarcoidosis Presenting with Tracheobronchial Calcification and Nodularity: An Unusual Case Presentation with Treatment Response Assessment by (18)F-FDG-PET/CT. Indian Journal of Nuclear Medicine : Ijnm : the Official Journal of the Society of Nuclear Medicine, India. 32: 217-220. PMID 28680208 DOI: 10.4103/ijnm.IJNM_152_16 |
0.216 |
|
| 2015 |
Thapa P, Basu S. Diagnosis of Dual Malignancy by 18F-FDG-PET/CT in the setting of Paraneoplastic Cerebellar Degeneration. Journal of Nuclear Medicine Technology. PMID 26271804 DOI: 10.2967/jnmt.115.158659 |
0.216 |
|
| 2013 |
Upadhye T, Gandhi A, Basu S. Evaluation of (18)F-FDG Uptake Pattern in Brown Adipose Tissue Over Extended Time Period as Assessed by Multiple Time Point (18)F-FDG-PET. Nuclear Medicine and Molecular Imaging. 47: 89-97. PMID 24900088 DOI: 10.1007/s13139-012-0189-x |
0.215 |
|
| 2013 |
Lam MG, Kwee TC, Basu S, Alavi A. Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1510-1. PMID 23781014 DOI: 10.2967/jnumed.113.123273 |
0.215 |
|
| 2015 |
Ranade R, Kand P, Basu S. Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome). Nuclear Medicine Communications. 36: 1014-20. PMID 26049373 DOI: 10.1097/MNM.0000000000000350 |
0.215 |
|
| 2020 |
Kalshetty A, Basu S. PET/Computed Tomography in Pulmonary and Thoracic Inflammatory Diseases (Including Cardiac Sarcoidosis): The Current Role and Future Promises. Pet Clinics. 15: 163-173. PMID 32145887 DOI: 10.1016/j.cpet.2019.11.008 |
0.214 |
|
| 2008 |
Basu S, Alavi A. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer? European Journal of Nuclear Medicine and Molecular Imaging. 34: 1527-9. PMID 17522857 DOI: 10.1007/s00259-007-0467-5 |
0.214 |
|
| 2015 |
Basu S, Ranade R. 18-Fluoro-deoxyglucose-PET/Computed Tomography in Infection and Aseptic Inflammatory Disorders: Value to Patient Management. Pet Clinics. 10: 431-9. PMID 26099677 DOI: 10.1016/j.cpet.2015.03.006 |
0.214 |
|
| 2020 |
Parghane RV, Mitra A, Upadhye T, Rakshit S, Banerjee S, Basu S. Sequential Duo-Peptide Receptor Radionuclide Therapy With Indigenous 90Y-DOTATATE and 177Lu-DOTATATE in Large-Volume Neuroendocrine Tumors: Posttherapy Bremsstrahlung and PET/CT Imaging Following 90Y-DOTATATE Treatment. Clinical Nuclear Medicine. PMID 32657872 DOI: 10.1097/RLU.0000000000003182 |
0.214 |
|
| 2011 |
Basu S, Desai SB. Solitary anterior abdominal wall metastasis from osteogenic sarcoma of fibula as detected by FDG-PET imaging. Journal of Cancer Research and Therapeutics. 7: 229-30. PMID 21768725 DOI: 10.4103/0973-1482.82935 |
0.214 |
|
| 2010 |
Kand PG, Tiwari BP, Basu S, Asopa RV, Nayak UN. Exploring the role of FDG-PET in the assessment of bone marrow involvement in lymphoma patients as interpreted by qualitative and semiquantitative disease metabolic activity parameter Indian Journal of Cancer. 47: 380-384. PMID 21131749 DOI: 10.4103/0019-509X.73569 |
0.213 |
|
| 2012 |
Hess S, Madsen PH, Basu S, Høilund-Carlsen PF, Alavi A. Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders. Clinical Nuclear Medicine. 37: 1170-2. PMID 23154475 DOI: 10.1097/RLU.0b013e318279bf73 |
0.213 |
|
| 2009 |
Kapoor J, Basu S, Menon S. Subcutaneous metastasis in esophageal carcinoma detected by FDG-PET Imaging. Indian Journal of Cancer. 46: 354-5. PMID 19749476 DOI: 10.4103/0019-509X.55565 |
0.213 |
|
| 2007 |
Basu S, Mavi A, Cermik T, Houseni M, Alavi A. Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology? Molecular Imaging and Biology. 10: 62-6. PMID 18000713 DOI: 10.1007/s11307-007-0121-4 |
0.212 |
|
| 2009 |
Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Seminars in Nuclear Medicine. 39: 36-51. PMID 19038599 DOI: 10.1053/j.semnuclmed.2008.08.004 |
0.212 |
|
| 2012 |
Basu S, Høilund-Carlsen PF, Alavi A. Assessing global cardiovascular molecular calcification with 18F-fluoride PET/CT: will this become a clinical reality and a challenge to CT calcification scoring? European Journal of Nuclear Medicine and Molecular Imaging. 39: 660-4. PMID 22274730 DOI: 10.1007/s00259-011-2048-x |
0.211 |
|
| 2018 |
Fargose P, Basu S. Discordant Primary Resistance to Imatinib Mesylate in the Same Individual and Splenic Involvement in Recurring Gastric Gastrointestinal Stromal Tumors: Assessment by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography. Indian Journal of Nuclear Medicine : Ijnm : the Official Journal of the Society of Nuclear Medicine, India. 33: 140-142. PMID 29643676 DOI: 10.4103/ijnm.IJNM_142_17 |
0.211 |
|
| 2007 |
Alavi A, Mavi A, Basu S, Fischman A. Is PET-CT the only option? European Journal of Nuclear Medicine and Molecular Imaging. 34: 819-21. PMID 17216469 DOI: 10.1007/s00259-006-0340-y |
0.21 |
|
| 2007 |
Basu S, Zaidi H, Alavi A. Clinical and Research Applications of Quantitative PET Imaging. Pet Clinics. 2: 161-72. PMID 27157871 DOI: 10.1016/j.cpet.2007.10.002 |
0.21 |
|
| 2020 |
Adnan A, Basu S. Metastatic Prostate Adenocarcinoma with Urinary Bladder involvement by two different routes (direct extension and hematogenous seeding): Dual tracer PET (Ga-PSMA-11 and FDG) and CT Imaging features and their role in assessing and predicting response to Lu-PSMA-617 Radioligand Therapy vis-à-vis conventional risk categories. Journal of Nuclear Medicine Technology. PMID 32111660 DOI: 10.2967/jnmt.119.235960 |
0.21 |
|
| 2013 |
Basu S. Developing a unified imaging approach for neuroendocrine tumours with the evolution of PET-CT with ⁶⁸Ga-labelled somatostatin analogues: could this be tailored according to specific clinical context and individual patient requirement? Nuclear Medicine Communications. 33: 1007-10. PMID 22850607 DOI: 10.1097/MNM.0b013e32835710a3 |
0.209 |
|
| 2014 |
Basu S, Borde C, Kand P. Increasing cardiac ¹⁸F-fluorodeoxyglucose (FDG) uptake on PET-CT as a biomarker for cardiotoxicity of chemo-radiotherapy in cancer: a myth or a reality? Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 112: 451-2. PMID 25017999 DOI: 10.1016/j.radonc.2014.04.019 |
0.209 |
|
| 2019 |
Jagtap R, Asopa RV, Basu S. Evaluating cardiac hypoxia in hibernating myocardium: Comparison of Tc-MIBI/F-fluorodeoxyglucose and F-fluoromisonidazole positron emission tomography-computed tomography in relation to normal, hibernating, and infarct myocardium. World Journal of Nuclear Medicine. 18: 30-35. PMID 30774543 DOI: 10.4103/wjnm.WJNM_16_18 |
0.209 |
|
| 2011 |
Basu S, Shet T. FDG avid "abdominal band" representing omental cake in mucinous adenocarcinoma of the appendix: potential implications for disease monitoring with FDG-PET in this setting. Journal of Cancer Research and Therapeutics. 7: 231-3. PMID 21768727 DOI: 10.4103/0973-1482.82939 |
0.209 |
|
| 2008 |
Basu S. Functional mapping of pattern and probability of locoregional and distant metastases: can FDG-PET/CT imaging data be the basis for multidimensional scaling in patients with cancer? European Journal of Nuclear Medicine and Molecular Imaging. 35: 1736-7. PMID 18542954 DOI: 10.1007/s00259-008-0854-6 |
0.208 |
|
| 2016 |
Desai U, Karkhanis VS, Basu S, Joshi JM. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in idiopathic pulmonary fibrosis: A new ray of hope! Indian Journal of Nuclear Medicine. 31: 283-285. DOI: 10.4103/0972-3919.187456 |
0.207 |
|
| 2006 |
Basu S, Nair N. Is it time to incorporate quantitative functional imaging data, FDG PET in particular, into the response evaluation criteria in solid tumours? Nuclear Medicine Communications. 27: 413-416. PMID 16609351 DOI: 10.1097/00006231-200605000-00001 |
0.207 |
|
| 2015 |
Kwee TC, Basu S, Alavi A. Should the nuclear medicine community continue to underestimate the potential of 18F-FDG-PET/CT with present generation scanners for the diagnosis of prosthetic joint infection? Nuclear Medicine Communications. 36: 756-7. PMID 26020607 DOI: 10.1097/MNM.0000000000000318 |
0.207 |
|
| 2009 |
Kumar R, Rani N, Patel C, Basu S, Alavi A. False-Negative and False-Positive Results in FDG-PET and PET/CT in Breast Cancer. Pet Clinics. 4: 289-98. PMID 27157101 DOI: 10.1016/j.cpet.2009.09.002 |
0.207 |
|
| 2015 |
Abhyankar A, Desai SB, Asopa RV, Basu S. Unusual solitary splenic metastasis from pyriform fossa carcinoma detected by FDG-PET. Indian Journal of Cancer. 52: 524-5. PMID 26960464 DOI: 10.4103/0019-509X.178396 |
0.207 |
|
| 2007 |
Basu S, Nair N, Thorat M, Shet T. Uptake characteristics of FDG in multiple juvenile cellular fibroadenomata of the breast: FDG-PET and histopathologic correlation. Clinical Nuclear Medicine. 32: 203-4. PMID 17314596 DOI: 10.1097/01.RLU.0000255037.59458.FF |
0.207 |
|
| 2013 |
Basu S. The scope and potentials of functional radionuclide imaging towards advancing personalized medicine in oncology: Emphasis on PET-CT Discovery Medicine. 13: 65-73. PMID 22284785 |
0.206 |
|
| 2011 |
Basu S. 18F-FDG PET/CT as a sensitive and early treatment monitoring tool: will this become the major thrust for its clinical application in infectious and inflammatory disorders? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 165; author reply 16. PMID 22065874 DOI: 10.2967/jnumed.111.095026 |
0.206 |
|
| 2015 |
Marin-Oyaga VA, Salavati A, Houshmand S, Pasha AK, Gharavi M, Saboury B, Basu S, Torigian DA, Alavi A. Feasibility and performance of an adaptive contrast-oriented FDG PET/CT quantification technique for global disease assessment of malignant pleural mesothelioma and a brief review of the literature. Hellenic Journal of Nuclear Medicine. 18: 11-8. PMID 25679073 DOI: 10.1967/s002449910162 |
0.206 |
|
| 2006 |
Basu S, Nair N. Unilateral testicular relapse of abdominal non-Hodgkin lymphoma detected by FDG-PET Pediatric Radiology. 36: 274-275. PMID 16328321 DOI: 10.1007/s00247-005-0040-y |
0.205 |
|
| 2014 |
Basu S, Mahajan A. Psoas muscle metastasis from cervical carcinoma: Correlation and comparison of diagnostic features on FDG-PET/CT and diffusion-weighted MRI. World Journal of Radiology. 6: 125-9. PMID 24778775 DOI: 10.4329/wjr.v6.i4.125 |
0.205 |
|
| 2014 |
Basu S. Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct? European Journal of Nuclear Medicine and Molecular Imaging. 41: 2354-5. PMID 25201009 DOI: 10.1007/s00259-014-2908-2 |
0.205 |
|
| 2014 |
Basu S, Zaidi H, Salavati A, Hess S, Carlsen PF, Alavi A. FDG PET/CT methodology for evaluation of treatment response in lymphoma: from "graded visual analysis" and "semiquantitative SUVmax" to global disease burden assessment. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2158-60. PMID 24993455 DOI: 10.1007/s00259-014-2826-3 |
0.204 |
|
| 2009 |
Basu S. Characterization of hilar and mediastinal foci on18F-FDG PET: New variables Journal of Nuclear Medicine. 50: 489-490. PMID 19223415 DOI: 10.2967/jnumed.108.059683 |
0.204 |
|
| 2006 |
Basu S, Nair N. Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's Disease: A case study and review of the literature Journal of Neuro-Oncology. 80: 91-95. PMID 16850110 DOI: 10.1007/s11060-006-9161-x |
0.204 |
|
| 2009 |
Basu S, Ramani SK, Lad S. Unusual involvement of scalp and bilateral kidneys in an aggressive mediastinal diffuse large B cell lymphoma: documentation by FDG-PET imaging. Clinical Nuclear Medicine. 34: 638-41. PMID 19692836 DOI: 10.1097/RLU.0b013e3181b06abf |
0.204 |
|
| 2020 |
Parghane RV, Basu S. PET/Computed Tomography in Treatment Response Assessment in Cancer: An Overview with Emphasis on the Evolving Role in Response Evaluation to Immunotherapy and Radiation Therapy. Pet Clinics. 15: 101-123. PMID 31735297 DOI: 10.1016/j.cpet.2019.08.005 |
0.204 |
|
| 2009 |
Salavati A, Basu S, Heidari P, Alavi A. Impact of fluorodeoxyglucose PET on the management of esophageal cancer. Nuclear Medicine Communications. 30: 95-116. PMID 19194210 DOI: 10.1097/MNM.0b013e32831af204 |
0.204 |
|
| 2014 |
Ranade R, Thapa P, Basu S. Adrenal metastasis from differentiated thyroid carcinoma documented on post-therapy (131)I scan: A case based discussion. World Journal of Radiology. 6: 56-61. PMID 24765241 DOI: 10.4329/wjr.v6.i3.56 |
0.203 |
|
| 2009 |
Sanz-Viedma S, Torigian D, Parsons M, Basu S, Alavi A. Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging Revista EspañOla De Medicina Nuclear. 28: 159-166. DOI: 10.1016/S0212-6982(09)71360-6 |
0.203 |
|
| 2007 |
Cermik TF, Mavi A, Basu S, Alavi A. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 35: 475-83. PMID 17957366 DOI: 10.1007/s00259-007-0580-5 |
0.203 |
|
| 2009 |
Tchou J, Sonnad SS, Bergey MR, Basu S, Tomaszewski J, Alavi A, Schnall M. Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer. Molecular Imaging and Biology. 12: 657-62. PMID 20012701 DOI: 10.1007/S11307-009-0294-0 |
0.202 |
|
| 2016 |
Sampathirao N, Basu S. Rare Occurrence Of Hypergastrinemia due to Thoracic Neuroendocrine Tumor: Detection and Characterization by 68Ga-DOTATATE PET-CT. Journal of Nuclear Medicine Technology. PMID 26848167 DOI: 10.2967/jnmt.115.171603 |
0.202 |
|
| 2011 |
Yang H, Chryssikos T, Houseni M, Alzeair S, Sansovini M, Iruvuri S, Torigian DA, Zhuang H, Dadparvar S, Basu S, Alavi A. The effects of aging on testicular volume and glucose metabolism: an investigation with ultrasonography and FDG-PET. Molecular Imaging and Biology. 13: 391-8. PMID 20521135 DOI: 10.1007/s11307-010-0341-x |
0.202 |
|
| 2019 |
Jadhav S, Basu S. Metastatic large cell neuroendocrine carcinoma of larynx: Individualizing tumor biology by dual tracer positron emission tomography/computed tomography (Ga-DOTATATE and F-fluorodeoxyglucose) molecular imaging and disease stabilization following Lu-DOTATATE peptide receptor radionuclide therapy after initial progression on chemoradiotherapy. World Journal of Nuclear Medicine. 18: 431-433. PMID 31933564 DOI: 10.4103/wjnm.WJNM_76_18 |
0.202 |
|
| 2009 |
Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Seminars in Nuclear Medicine. 39: 124-45. PMID 19187805 DOI: 10.1053/j.semnuclmed.2008.10.006 |
0.202 |
|
| 2015 |
Basu S, Kumar R, Ranade R. Assessment of treatment response using PET. Pet Clinics. 10: 9-26. PMID 25455877 DOI: 10.1016/j.cpet.2014.09.002 |
0.201 |
|
| 2014 |
Masangkay N, Basu S, Moghbel M, Kwee T, Alavi A. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. Nuclear Medicine Communications. 35: 1038-46. PMID 25023997 DOI: 10.1097/MNM.0000000000000163 |
0.201 |
|
| 2012 |
Basu S, Beheshti M, Alavi A. Value of (18)F NaF PET/CT in the Detection and Global Quantification of Cardiovascular Molecular Calcification as Part of the Atherosclerotic Process. Pet Clinics. 7: 329-39. PMID 27157462 DOI: 10.1016/j.cpet.2012.04.006 |
0.201 |
|
| 2017 |
Kundu S, Kand P, Basu S. Comparative evaluation of iodine-131 metaiodobenzylguanidine and 18-fluorodeoxyglucose positron emission tomography in assessing neural crest tumors: Will they play a complementary role? South Asian Journal of Cancer. 6: 31-34. PMID 28413794 DOI: 10.4103/2278-330X.202556 |
0.199 |
|
| 2014 |
Hess S, Hansson SH, Pedersen KT, Basu S, Høilund-Carlsen PF. FDG-PET/CT in Infectious and Inflammatory Diseases. Pet Clinics. 9: 497-519, vi-vii. PMID 26050949 DOI: 10.1016/j.cpet.2014.07.002 |
0.199 |
|
| 2017 |
Ranade R, Basu S. Metabolic Bone Disease in the Context of Metastatic Neuroendocrine Tumor: Differentiation from Skeletal Metastasis, the Molecular PET-CT Imaging Features, and Exploring the Possible Etiopathologies Including Parathyroid Adenoma (MEN1) and Paraneoplastic Humoral Hypercalcemia of Malignancy Due to PTHrP Hypersecretion. World Journal of Nuclear Medicine. 16: 62-67. PMID 28217023 DOI: 10.4103/1450-1147.172307 |
0.199 |
|
| 2015 |
Pawaskar AS, Basu S. Role of 2-Fluoro-2-Deoxyglucose PET/Computed Tomography in Carcinoma of Unknown Primary. Pet Clinics. 10: 297-310. PMID 26099668 DOI: 10.1016/j.cpet.2015.03.004 |
0.198 |
|
| 2011 |
Gupta K, Pawaskar A, Basu S, Rajan MG, Asopa RV, Arora B, Nair N, Banavali S. Potential role of FDG PET imaging in predicting metastatic potential and assessment of therapeutic response to neoadjuvant chemotherapy in Ewing sarcoma family of tumors. Clinical Nuclear Medicine. 36: 973-7. PMID 21975382 DOI: 10.1097/RLU.0b013e31822f684b |
0.197 |
|
| 2016 |
Kwee TC, Basu S, Alavi A. Letter: Opinion on favoring labeled leukocyte imaging over 18F-FDG-PET for diagnosing prosthetic joint infection: Rectifying ongoing misconceptions. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27516445 DOI: 10.2967/jnumed.116.181461 |
0.197 |
|
| 2012 |
Borde C, Kand P, Basu S. Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity? World Journal of Radiology. 4: 220-3. PMID 22761982 DOI: 10.4329/wjr.v4.i5.220 |
0.196 |
|
| 2012 |
Aliyev A, Saboury B, Kwee TC, Torigian DA, Basu S, Wulff Christensen H, Alavi A. Age-related inflammatory changes in the spine as demonstrated by (18)F-FDG-PET:observation and insight into degenerative spinal changes. Hellenic Journal of Nuclear Medicine. 15: 197-201. PMID 23106050 DOI: 10.1967/s002449910054 |
0.196 |
|
| 2015 |
Basu S, C. Kwee T, Hess S. FDG-PET/CT Imaging of Infected Bones and Prosthetic Joints Current Molecular Imaging. 3: 225-229. DOI: 10.2174/2211555204666150619153219 |
0.196 |
|
| 2010 |
Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clinical Nuclear Medicine. 35: 960-1. PMID 21206232 DOI: 10.1097/RLU.0b013e3181f9ded7 |
0.195 |
|
| 2021 |
Adnan A, Basu S. Concept proposal for a six-tier integrated dual tracer PET-CT (68Ga-PSMA and FDG) image scoring system ('Pro-PET' score) and examining its potential implications in metastatic castration-resistant prostate carcinoma theranostics and prognosis. Nuclear Medicine Communications. PMID 33560718 DOI: 10.1097/MNM.0000000000001371 |
0.194 |
|
| 2019 |
Basu S, Adnan A. Well-differentiated grade 3 neuroendocrine tumours and poorly differentiated grade 3 neuroendocrine carcinomas: will dual tracer PET-computed tomography (68Ga-DOTATATE and FDG) play a pivotal role in differentiation and guiding management strategies? Nuclear Medicine Communications. PMID 31365493 DOI: 10.1097/MNM.0000000000001072 |
0.194 |
|
| 2015 |
Saboury B, Parsons MA, Moghbel M, Rubello D, Brothers A, Torigian DA, Werner TJ, Houshmand S, Basu S, Lam MG, Alavi A. Quantification of aging effects upon global knee inflammation by 18F-FDG-PET. Nuclear Medicine Communications. PMID 26555103 DOI: 10.1097/MNM.0000000000000430 |
0.194 |
|
| 2007 |
Bural GG, Torigian DA, Chamroonrat W, Houseni M, Chen W, Basu S, Kumar R, Alavi A. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. European Journal of Nuclear Medicine and Molecular Imaging. 35: 562-9. PMID 17957367 DOI: 10.1007/s00259-007-0528-9 |
0.193 |
|
| 2007 |
Basu S, Nair N, Baghel NS. A hypermetabolic abdominal focus in a case of osteogenic sarcoma on 18FDG-PET: in vivo insight into the gravid myometrial metabolism pattern. The British Journal of Radiology. 80: 851-2. PMID 17959925 DOI: 10.1259/BJR/64866111 |
0.193 |
|
| 2012 |
Basu S, Ramani SK, Ramadwar M. Breast recurrence of primary rectal lymphoma: documentation by (18)F-FDG-PET and histopathology. Hellenic Journal of Nuclear Medicine. 15: 153-4. PMID 22741152 DOI: 10.1967/s002449910034 |
0.193 |
|
| 2011 |
Basu S, Tiwari BP. Complimentary role of FDG-PET imaging and skeletal scintigraphy in the evaluation of patients of prostate carcinoma Indian Journal of Cancer. 48: 513-514. PMID 22293270 DOI: 10.4103/0019-509X.92247 |
0.192 |
|
| 2007 |
Basu S, Alavi A. Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites? European Journal of Nuclear Medicine and Molecular Imaging. 34: 604-5. PMID 17206414 DOI: 10.1007/s00259-006-0315-z |
0.191 |
|
| 2013 |
Kwee TC, Basu S, Torigian DA, Zhuang H, Alavi A. FDG PET imaging for diagnosing prosthetic joint infection: discussing the facts, rectifying the unsupported claims and call for evidence-based and scientific approach. European Journal of Nuclear Medicine and Molecular Imaging. 40: 464-6. PMID 23296643 DOI: 10.1007/s00259-012-2319-1 |
0.191 |
|
| 2015 |
Hess S, Basu S, A. Blomberg B, Lam M, C. Moghbel M, J. Zhu H, Mirzaei S, Alavi A, F. Hoilund-Carlsen P. The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond Current Molecular Imaging. 4: 2-19. DOI: 10.2174/2211555204666150710175824 |
0.191 |
|
| 2005 |
Nair N, Basu S. Unsuspected metastatic male breast nodule from synovial sarcoma detected by FDG PET Clinical Nuclear Medicine. 30: 289-290. PMID 15764896 DOI: 10.1097/01.rlu.0000156948.62084.50 |
0.19 |
|
| 2004 |
Basu S, Nair N. Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin's disease: Hepatic 'superscan' Clinical Nuclear Medicine. 29: 626-628. PMID 15365434 DOI: 10.1097/00003072-200410000-00005 |
0.19 |
|
| 2007 |
Basu S, Alzeair S, Li G, Dadparvar S, Alavi A. Etiopathologies associated with intercostal muscle hypermetabolism and prominent right ventricle visualization on 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography: significance of an incidental finding and in the setting of a known pulmonary disease. Molecular Imaging and Biology. 9: 333-9. PMID 17610018 DOI: 10.1007/s11307-007-0102-7 |
0.189 |
|
| 2015 |
Basu S, Ranade R, Hazarika S. 68Ga DOTATATE PET/CT of Synchronous Meningioma and Prolactinoma. Clinical Nuclear Medicine. PMID 26462040 DOI: 10.1097/RLU.0000000000001021 |
0.189 |
|
| 2017 |
Bhatkar D, Utpat K, Basu S, Joshi JM. Dual Tracer PET Imaging (68Ga-DOTATATE and 18F-FDG) Features in Pulmonary Carcinoid: Correlation with Tumor Proliferation Index. Indian Journal of Nuclear Medicine : Ijnm : the Official Journal of the Society of Nuclear Medicine, India. 32: 39-41. PMID 28242984 DOI: 10.4103/0972-3919.198476 |
0.189 |
|
| 2016 |
Basu S, Ranade R, Thapa P. Metastatic Neuroendocrine Tumor with Extensive Bone Marrow Involvement at Diagnosis: Evaluation of Response and Hematological Toxicity Profile of PRRT with (177)Lu-DOTATATE. World Journal of Nuclear Medicine. 15: 38-43. PMID 26912977 DOI: 10.4103/1450-1147.165353 |
0.188 |
|
| 2015 |
Basu S. Indirect evidences of functionality of insulinoma on FDG-PET: The 'whole body-metabolism' advantage and its clinical implications. Indian Journal of Cancer. 52: 68-9. PMID 26837978 DOI: 10.4103/0019-509X.175558 |
0.187 |
|
| 2013 |
Cheng G, Kwee TC, Basu S, Alavi A. Critical considerations on the combined use of ¹⁸F-FDG and ¹⁸F-fluoride for PET assessment of metastatic bone disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 1141-5. PMID 23695838 DOI: 10.1007/s00259-013-2459-y |
0.186 |
|
| 2016 |
Basu S, Joshi A. 68Ga DOTATATE PET/CT in Differentiated Thyroid Carcinoma With Fibular Metastasis and Mixed Response to Sorafenib. Clinical Nuclear Medicine. PMID 27500511 DOI: 10.1097/RLU.0000000000001327 |
0.186 |
|
| 2017 |
Kumar NS, Shejul Y, Asopa R, Basu S. Quantitative Metabolic Volumetric Product on (18)Fluorine-2fluoro-2-deoxy-D-glucose-positron Emission Tomography/Computed Tomography in Assessing Treatment Response to Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Multiparametric Analysis Integrating American College of Rheumatology/European League Against Rheumatism Criteria. World Journal of Nuclear Medicine. 16: 293-302. PMID 29033678 DOI: 10.4103/1450-1147.215492 |
0.186 |
|
| 2012 |
Nawaz A, Saboury B, Basu S, Zhuang H, Moghadam-Kia S, Werner T, Mohler ER, Torigian DA, Alavi A. Relation between popliteal-tibial artery atherosclerosis and global glycolytic metabolism in the affected diabetic foot: a pilot study using quantitative FDG-PET. Journal of the American Podiatric Medical Association. 102: 240-6. PMID 22659767 DOI: 10.7547/1020240 |
0.186 |
|
| 2009 |
Kumar R, Chawla M, Basu S, Alavi A. PET and PET-CT Imaging in Treatment Monitoring of Breast Cancer. Pet Clinics. 4: 359-69. PMID 27157305 DOI: 10.1016/j.cpet.2009.09.008 |
0.185 |
|
| 2017 |
Basu S, Kalshetty A. Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials? European Journal of Nuclear Medicine and Molecular Imaging. PMID 28236023 DOI: 10.1007/s00259-017-3648-x |
0.184 |
|
| 2016 |
Basu S, Ostwal V. Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors? Nuclear Medicine Communications. 37: 669-671. PMID 27105440 DOI: 10.1097/MNM.0000000000000507 |
0.184 |
|
| 2009 |
Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Molecular Imaging and Biology. 12: 335-42. PMID 19816744 DOI: 10.1007/s11307-009-0268-2 |
0.184 |
|
| 2016 |
Basu S, Ranade R, Thapa P. 177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT aid in personalized treatment decision making in selecting the best therapeutic option? Nuclear Medicine Communications. 37: 100-102. PMID 26587985 DOI: 10.1097/MNM.0000000000000397 |
0.183 |
|
| 2021 |
Basu S, Parghane R. Follicular thyroid carcinoma metastasizing to rare sites and exhibiting variable inter-lesional heterogeneity on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and 131I World Journal of Nuclear Medicine. 20: 312. DOI: 10.4103/wjnm.wjnm_79_20 |
0.183 |
|
| 2014 |
Jois B, Asopa R, Basu S. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation. Clinical Nuclear Medicine. 39: 505-10. PMID 24662668 DOI: 10.1097/RLU.0000000000000429 |
0.182 |
|
| 2020 |
Sharma P, Basu S. Occurrence of 'Redifferentiation akin' phenomenon on [Ga]Ga-DOTATATE PET-CT following CAPTEM chemotherapy in Metastatic Neuroendocrine Tumours with intermediate MiB-1 index: what could be the molecular explanation? Journal of Nuclear Medicine Technology. PMID 32111657 DOI: 10.2967/jnmt.120.241539 |
0.182 |
|
| 2010 |
Basu S, Shet T. Unilateral solitary breast metastasis from medullary carcinoma of thyroid detected by FDG-PET. Clinical Nuclear Medicine. 35: 512-3. PMID 20548144 DOI: 10.1097/RLU.0b013e3181e0607f |
0.182 |
|
| 2008 |
Basu S, Torigian D, Alavi A. Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET. European Journal of Nuclear Medicine and Molecular Imaging. 35: 465-71. PMID 17955239 DOI: 10.1007/s00259-007-0593-0 |
0.181 |
|
| 2013 |
Basu S. Ring-enhancing brain lesions, clinical presentation of focal seizures, and inconclusive anatomical neuroimaging features: can 18F-FDG-PET/CT play an adjunct role in bettering diagnosis in this setting? Nuclear Medicine Communications. 34: 1237-9. PMID 24157900 DOI: 10.1097/MNM.0000000000000007 |
0.181 |
|
| 2015 |
Pasha AK, Moghbel M, Saboury B, Gharavi MH, Blomberg BA, Torigian DA, Kwee TC, Basu S, Mohler Iii ER, Alavi A. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries. Hellenic Journal of Nuclear Medicine. 18: 5-10. PMID 25679072 DOI: 10.1967/s002449910161 |
0.18 |
|
| 2007 |
Fan C, Hernandez-Pampaloni M, Houseni M, Chamroonrat W, Basu S, Kumar R, Dadparvar S, Torigian DA, Alavi A. Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography. Molecular Imaging and Biology. 9: 300-7. PMID 17574502 DOI: 10.1007/s11307-007-0100-9 |
0.179 |
|
| 2014 |
Rachh S, Basu S. PET/CT in patients with liver lesions of different nature Clinical and Translational Imaging. 2: 139-155. DOI: 10.1007/s40336-014-0061-3 |
0.179 |
|
| 2020 |
Basu S, Parghane RV, Kamaldeep, Chakrabarty S. Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors. Seminars in Nuclear Medicine. 50: 447-464. PMID 32768008 DOI: 10.1053/j.semnuclmed.2020.05.004 |
0.179 |
|
| 2006 |
Basu S, Alavi A. FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies. European Journal of Nuclear Medicine and Molecular Imaging. 34: 427-8. PMID 17195072 DOI: 10.1007/s00259-006-0313-1 |
0.177 |
|
| 2010 |
Basu S, Baghel NS. FDG PET in ruptured pulmonary hydatid cyst: assessing disease extent and tracking the path of drainage. Clinical Nuclear Medicine. 35: 471-2. PMID 20479608 DOI: 10.1097/RLU.0b013e3181db4ee3 |
0.177 |
|
| 2019 |
Basu S, Parghane RV, Suman S, Joshi A, Prabhash K, Bakshi G, Banerjee S. Towards personalizing treatment strategies in mCRPC: can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course? European Journal of Nuclear Medicine and Molecular Imaging. PMID 31776630 DOI: 10.1007/s00259-019-04616-w |
0.175 |
|
| 2016 |
Ranade R, Pawar S, Mahajan A, Basu S. Unusual False Positive Radioiodine Uptake on (131)I Whole Body Scintigraphy in Three Unrelated Organs with Different Pathologies in Patients of Differentiated Thyroid Carcinoma: A Case Series. World Journal of Nuclear Medicine. 15: 137-41. PMID 27134566 DOI: 10.4103/1450-1147.176884 |
0.175 |
|
| 2017 |
Naik C, Basu S. Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE for Metastatic Neuroendocrine Tumor Occurring in Association with Multiple Endocrine Neoplasia Type 1 and Cushing's Syndrome. World Journal of Nuclear Medicine. 16: 126-132. PMID 28553179 DOI: 10.4103/1450-1147.203068 |
0.175 |
|
| 2016 |
Basu S, Fargose P. 177Lu-DOTATATE PRRT as promising new treatment approach in Recurrent Skull Base Phosphaturic Mesenchymal Tumor causing paraneoplastic oncogenic osteomalacia: a potential therapeutic application of PRRT beyond NET. Journal of Nuclear Medicine Technology. PMID 27634982 DOI: 10.2967/jnmt.116.177873 |
0.174 |
|
| 2008 |
Basu S, Alavi A. Feasibility of automated partial-volume correction of SUVs in current PET/CT scanners: can manufacturers provide integrated, ready-to-use software? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1031-2; author reply. PMID 18483094 DOI: 10.2967/jnumed.108.050401 |
0.174 |
|
| 2007 |
Basu S, Zaidi H, Houseni M, Bural G, Udupa J, Acton P, Torigian DA, Alavi A. Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. Seminars in Nuclear Medicine. 37: 223-39. PMID 17418154 DOI: 10.1053/J.SEMNUCLMED.2007.01.005 |
0.174 |
|
| 2014 |
Sorokin J, Saboury B, Ahn JA, Moghbel M, Basu S, Alavi A. Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain". Clinical Nuclear Medicine. 39: e35-9. PMID 23751834 DOI: 10.1097/Rlu.0B013E318292Aa81 |
0.172 |
|
| 2012 |
Abhyankar A, Joshi J, Basu S. FDG uptake in unilateral breast related to breastfeeding practice in a patient of pulmonary hydatid cyst. Clinical Nuclear Medicine. 37: 676-8. PMID 22691511 DOI: 10.1097/RLU.0b013e31824d210d |
0.171 |
|
| 2012 |
Basu S, Gupta T, Jalali R, Shet T. Detecting bone marrow metastasis in cerebellar medulloblastoma: value of disease surveillance with FDG-PET in this setting. Indian Journal of Cancer. 48: 373-4. PMID 21921346 DOI: 10.4103/0019-509X.84922 |
0.171 |
|
| 2015 |
Basu S, Mahajan A. Metachronous second primary of sigmoid colon presenting as an atypical extraluminal pedunculated polypoidal fluorodeoxyglucose-positron emission tomography-computed tomography incidentaloma Clinical Cancer Investigation Journal. 4: 289. DOI: 10.4103/2278-0513.148913 |
0.169 |
|
| 2011 |
Basu S, Alavi A. Emerging role of FDG-PET for optimal response assessment in infectious diseases and disorders. Expert Review of Anti-Infective Therapy. 9: 143-5. PMID 21342059 DOI: 10.1586/eri.10.167 |
0.169 |
|
| 2013 |
Basu S, Chouhan A. Striking asymmetry in cerebral metabolism in Dyke-Davidoff-Masson (DDM) syndrome: FDG-PET and MRI correlation. Acta Neurochirurgica. 155: 519-21. PMID 23299848 DOI: 10.1007/s00701-012-1604-x |
0.168 |
|
| 2015 |
Iyer K, Karkhanis V, Basu S, Joshi JM. Fluro-deoxygenase-positron emission tomography/computed tomography in hard metal lung disease. Lung India : Official Organ of Indian Chest Society. 32: 480-482. PMID 26628763 DOI: 10.4103/0970-2113.164160 |
0.168 |
|
| 2014 |
Abdulla S, Salavati A, Saboury B, Basu S, Torigian DA, Alavi A. Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 41: 350-6. PMID 24085504 DOI: 10.1007/s00259-013-2579-4 |
0.167 |
|
| 2009 |
Srinivas SM, Dhurairaj T, Basu S, Bural G, Surti S, Alavi A. A recovery coefficient method for partial volume correction of PET images. Annals of Nuclear Medicine. 23: 341-8. PMID 19367446 DOI: 10.1007/S12149-009-0241-9 |
0.167 |
|
| 2010 |
Basu S. Personalized versus evidence-based medicine with PET-based imaging. Nature Reviews. Clinical Oncology. 7: 665-8. PMID 20700107 DOI: 10.1038/nrclinonc.2010.121 |
0.167 |
|
| 2007 |
Basu S, Houseni M, Bural G, Chamroonat W, Udupa J, Mishra S, Alavi A. Magnetic resonance imaging based bone marrow segmentation for quantitative calculation of pure red marrow metabolism using 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a novel application with significant implications for combined structure-function approach. Molecular Imaging and Biology. 9: 361-5. PMID 17899296 DOI: 10.1007/s11307-007-0112-5 |
0.166 |
|
| 2007 |
Abramson RG, Mavi A, Cermik T, Basu S, Wehrli NE, Houseni M, Mishra S, Udupa J, Lakhani P, Maidment AD, Torigian DA, Alavi A. Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography. Seminars in Nuclear Medicine. 37: 146-53. PMID 17418148 DOI: 10.1053/j.semnuclmed.2007.01.003 |
0.165 |
|
| 2010 |
Basu S. From pure research imaging tool to PET-guided personalized medicine in oncology: a true revolution in modern medicine. Indian Journal of Cancer. 47: 98-9. PMID 20448370 DOI: 10.4103/0019-509X.62994 |
0.164 |
|
| 2012 |
Moghbel MC, Saboury B, Basu S, Metzler SD, Torigian DA, Långström B, Alavi A. Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies? European Journal of Nuclear Medicine and Molecular Imaging. 39: 202-8. PMID 22009379 DOI: 10.1007/s00259-011-1960-4 |
0.164 |
|
| 2017 |
Shinde V, Basu S. Fluorodeoxyglucose-avid pulmonary mucinous adenocarcinoma presenting with nonfluorodeoxyglucose-avid cystic brain lesions of unknown etiopathology: Brain magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography-computed tomography imaging features and additional value of whole-body positron emission tomography acquisition. Indian Journal of Cancer. 54: 81-82. PMID 29199669 DOI: 10.4103/0019-509X.219578 |
0.164 |
|
| 2020 |
Menon BK, Kalshetty A, Bhattacharjee A, Basu S. Standardized uptake values and ratios on 68Ga-DOTATATE PET-computed tomography for normal organs and malignant lesions and their correlation with Krenning score in patients with metastatic neuroendocrine tumors. Nuclear Medicine Communications. PMID 32732598 DOI: 10.1097/MNM.0000000000001253 |
0.163 |
|
| 2008 |
Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Cancer. 112: 995-1000. PMID 18098228 DOI: 10.1002/Cncr.23226 |
0.163 |
|
| 2014 |
Basu S, Kwee TC, Saboury B, Garino JP, Nelson CL, Zhuang H, Parsons M, Chen W, Kumar R, Salavati A, Werner TJ, Alavi A. FDG PET for diagnosing infection in hip and knee prostheses: prospective study in 221 prostheses and subgroup comparison with combined (111)In-labeled leukocyte/(99m)Tc-sulfur colloid bone marrow imaging in 88 prostheses. Clinical Nuclear Medicine. 39: 609-15. PMID 24873788 DOI: 10.1097/RLU.0000000000000464 |
0.161 |
|
| 2014 |
Houshmand S, Salavati A, Basu S, Khiewvan B, Alavi A. The role of dual and multiple time point imaging of FDG uptake in both normal and disease states Clinical and Translational Imaging. 2: 281-293. DOI: 10.1007/s40336-014-0075-x |
0.161 |
|
| 2021 |
Parghane RV, Mitra A, Bannore TU, Rakshit S, Banerjee S, Basu S. Initial clinical evaluation of indigenous Y-DOTATATE in sequential duo-PRRT approach (Lu-DOTATATE and Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability, Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects. World Journal of Nuclear Medicine. 20: 73-81. PMID 33850492 DOI: 10.4103/wjnm.WJNM_52_20 |
0.16 |
|
| 2007 |
Basu S, Chryssikos T, Houseni M, Scot Malay D, Shah J, Zhuang H, Alavi A. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nuclear Medicine Communications. 28: 465-72. PMID 17460537 DOI: 10.1097/MNM.0b013e328174447f |
0.159 |
|
| 2008 |
Berkowitz A, Basu S, Srinivas S, Sankaran S, Schuster S, Alavi A. Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET. Nuclear Medicine Communications. 29: 521-6. PMID 18458598 DOI: 10.1097/MNM.0b013e3282f813a4 |
0.158 |
|
| 2015 |
Parsons MA, Moghbel M, Saboury B, Torigian DA, Werner TJ, Rubello D, Basu S, Alavi A. Increased 18F-FDG uptake suggests synovial inflammatory reaction with osteoarthritis: preliminary in-vivo results in humans. Nuclear Medicine Communications. PMID 26367212 DOI: 10.1097/MNM.0000000000000376 |
0.158 |
|
| 2011 |
Basu S, Kwee TC, Gatenby R, Saboury B, Torigian DA, Alavi A. Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders European Journal of Nuclear Medicine and Molecular Imaging. 38: 987-991. PMID 21451997 DOI: 10.1007/s00259-011-1787-z |
0.158 |
|
| 2007 |
Basu S, Zhuang H, Alavi A. Imaging of lower extremity artery atherosclerosis in diabetic foot: FDG-PET imaging and histopathological correlates. Clinical Nuclear Medicine. 32: 567-8. PMID 17581350 DOI: 10.1097/RLU.0B013E3180646AC0 |
0.157 |
|
| 2015 |
Basu S, Ranade R. Metastatic Merkel Cell Carcinoma responding favourably to targeted therapy with 177Lu-DOTATATE: will PRRT evolve as an important treatment approach in Receptor positive cases? Journal of Nuclear Medicine Technology. PMID 26471333 DOI: 10.2967/jnmt.115.163527 |
0.156 |
|
| 2019 |
Suman S, Parghane RV, Joshi A, Prabhash K, Bakshi G, Talole S, Banerjee S, Basu S. Therapeutic efficacy, Prognostic variables and Clinical Outcome of Lu-PSMA-617 PRLT in Progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-à-vis Gleason Score in such cohort. The British Journal of Radiology. 20190380. PMID 31600089 DOI: 10.1259/bjr.20190380 |
0.155 |
|
| 2018 |
Basu S, Pawaskar A. Individualized Management of Pyrexia of Unknown Origin: Will Fludeoxyglucose-positron Emission Tomography/Computed Tomography Emerge as the Imaging Common-point in the Algorithm? Indian Journal of Nuclear Medicine : Ijnm : the Official Journal of the Society of Nuclear Medicine, India. 33: 376-377. PMID 30386071 DOI: 10.4103/ijnm.IJNM_92_18 |
0.155 |
|
| 2009 |
Basu S. Early FDG-PET response-adapted risk stratification and further therapeutic decision-making in lymphoma: will this replace the established prognostic indices and be the standard-of-care in clinical management? European Journal of Nuclear Medicine and Molecular Imaging. 36: 2089-90. PMID 19862518 DOI: 10.1007/s00259-009-1296-5 |
0.154 |
|
| 1998 |
Basu S. Radioimmunosassay of 8-isoprostaglandin F(2α): An index for oxidative injury via free radical catalysed lipid peroxidation Prostaglandins Leukotrienes and Essential Fatty Acids. 58: 319-325. PMID 9654406 DOI: 10.1016/S0952-3278(98)90042-4 |
0.154 |
|
| 2017 |
Thapa P, Parghane R, Basu S. (177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites. World Journal of Nuclear Medicine. 16: 223-228. PMID 28670182 DOI: 10.4103/1450-1147.207283 |
0.154 |
|
| 2010 |
Basu S, Alavi A. PET: Widening Role Evaluating Infections Microbe Magazine. 5: 304-308. DOI: 10.1128/MICROBE.5.304.1 |
0.154 |
|
| 2005 |
Basu S, Nair N. 18F-FDG uptake in bilateral adrenal hyperplasia causing Cushing's syndrome European Journal of Nuclear Medicine and Molecular Imaging. 32: 384. PMID 15791448 DOI: 10.1007/s00259-004-1629-3 |
0.153 |
|
| 2009 |
Basu S, Rao R. Fluorodeoxyglucose-positron emission tomography imaging characteristics of unusual cystic metastasis on the liver surface arising from gallbladder carcinoma. Japanese Journal of Radiology. 27: 194-6. PMID 19499311 DOI: 10.1007/s11604-009-0319-2 |
0.152 |
|
| 2008 |
Basu S, Alavi A. Optimizing interventions for preventing uptake in the brown adipose tissue in FDG-PET. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1421-3. PMID 18350289 DOI: 10.1007/s00259-008-0720-6 |
0.152 |
|
| 2020 |
Ostwal V, Basu S, Bhargava P, Shah M, Parghane RV, Srinivas S, Chaudhari V, Bhandare MS, Shrikhande SV, Ramaswamy A. Capecitabine-Temozolomide (CAPTEM) in advanced Grade 2 and grade 3 Neuroendocrine neoplasms (NENs) - benefits of chemotherapy in NENs with significant 18FDG uptake. Neuroendocrinology. PMID 33017827 DOI: 10.1159/000511987 |
0.152 |
|
| 2016 |
Basu S, Alavi A. PET-Based Molecular Imaging in Evolving Personalized Management Design Pet Clinics. 11: i. DOI: 10.1016/S1556-8598(16)30039-6 |
0.151 |
|
| 2009 |
Cheville AL, Das I, Srinivas S, Schuerman J, Velders L, Solin LJ, Basu S, Alavi A. A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer. Breast Cancer Research and Treatment. 116: 531-8. PMID 19152027 DOI: 10.1007/s10549-008-0283-z |
0.151 |
|
| 2012 |
Basu S, Mallath MK. Understanding and fighting cancer cachexia syndrome: can PET help? Nuclear Medicine Communications. 33: 671-2. PMID 22395032 DOI: 10.1097/MNM.0b013e328352216f |
0.151 |
|
| 2007 |
Basu S, Alzeair S, Li G, Zhuang H, Alavi A. Intercostal muscle contraction or rib bone marrow activity?: Look for ancillary clues. Clinical Nuclear Medicine. 32: 739-40. PMID 17710034 DOI: 10.1097/RLU.0B013E318126C00A |
0.149 |
|
| 2011 |
Basu S. PET tracer for evaluating brain tumors: a clinical need-based rational approach. Nuclear Medicine Communications. 31: 763-5. PMID 20613679 DOI: 10.1097/MNM.0b013e32833ccae1 |
0.149 |
|
| 2018 |
Menon BK, Bhattacharjee A, Basu S. Comparison of Radioiodine uptake by Gamma Camera and Thyroid uptake probe-based methodologies and Diagnostic Radioiodine Scan in Differentiated thyroid carcinoma. Journal of Nuclear Medicine Technology. PMID 30413599 DOI: 10.2967/jnmt.118.207837 |
0.148 |
|
| 2010 |
Bural GG, Torigian DA, Burke A, Houseni M, Alkhawaldeh K, Cucchiara A, Basu S, Alavi A. Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: A novel concept Molecular Imaging and Biology. 12: 233-239. PMID 19806406 DOI: 10.1007/s11307-009-0258-4 |
0.146 |
|
| 1998 |
Basu S. Radioimmunoassay of 15-keto-13,14- dihydro-prostaglandin F(2α): An index for inflammation via cyclooxygenase catalysed lipid peroxidation Prostaglandins Leukotrienes and Essential Fatty Acids. 58: 347-352. PMID 9690712 DOI: 10.1016/S0952-3278(98)90070-9 |
0.144 |
|
| 2014 |
Basu S, Shejul Y. Regional lymph node hypermetabolism corresponding to the involved joints on FDG-PET in newly diagnosed patients of rheumatoid arthritis: observation and illustration in symmetrical and asymmetric joint involvement. Rheumatology International. 34: 413-5. PMID 23263493 DOI: 10.1007/s00296-012-2604-0 |
0.144 |
|
| 2004 |
Nair N, Basu S, Parkhale H. Unusual uptake of radioiodine in the chest in a patient with thyroid carcinoma British Journal of Radiology. 77: 63-67. PMID 14988142 DOI: 10.1259/bjr/54722743 |
0.144 |
|
| 2015 |
Abhyankar A, Basu S. Thymus uptake of (131) I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practice. Journal of Cancer Research and Therapeutics. 11: 648. PMID 26458613 DOI: 10.4103/0973-1482.143360 |
0.143 |
|
| 2020 |
Basu S, Parghane RV, Naik C. Clinical efficacy of Lu-DOTATATE peptide receptor radionuclide therapy in thyroglobulin-elevated negative iodine scintigraphy: A "not-so-promising" result compared to GEP-NETs. World Journal of Nuclear Medicine. 19: 205-210. PMID 33354174 DOI: 10.4103/wjnm.WJNM_21_19 |
0.143 |
|
| 2009 |
Basu S, Alavi A. Staging with PET and the "Will Rogers" effect: redefining prognosis and survival in patients with cancer. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1-4. PMID 17828536 DOI: 10.1007/s00259-007-0506-2 |
0.143 |
|
| 2012 |
Basu S, Abhyankar A. Role of SPECT/CT, versus traditional practices, in individualizing treatment of thyroid carcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1819; author reply 1. PMID 23042936 DOI: 10.2967/jnumed.112.110007 |
0.142 |
|
| 2009 |
Basu S, Alavi A. Multifaceted role of lymphatic mapping by SPECT/CT hybrid imaging in the multimodality management of patients with cancer. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1017-8. PMID 19387638 DOI: 10.1007/s00259-009-1130-0 |
0.142 |
|
| 2011 |
Basu S, Kwee TC, Torigian D, Saboury B, Alavi A. Suboptimal and inadequate quantification: An alarming crisis in medical applications of PET European Journal of Nuclear Medicine and Molecular Imaging. 38: 1381-1382. PMID 21424260 DOI: 10.1007/s00259-011-1766-4 |
0.141 |
|
| 2016 |
Basu B, Basu S. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management? Cancer Biotherapy & Radiopharmaceuticals. 31: 75-84. PMID 27093341 DOI: 10.1089/cbr.2015.1922 |
0.141 |
|
| 2009 |
Urhan M, Velioglu M, Rosenbaum J, Basu S, Alavi A. Imaging for the diagnosis of thyroid cancer. Expert Opinion On Medical Diagnostics. 3: 237-49. PMID 23488460 DOI: 10.1517/17530050902773513 |
0.139 |
|
| 1955 |
Basu S. F-centres in metaphosphate glass Nature. 176: 265-266. DOI: 10.1038/176265B0 |
0.137 |
|
| 2016 |
Basu S, Parghane R. Sub-segmenting Metastatic Thyroid Carcinoma into specific groups by Molecular functional imaging features: evolving Individualized Treatment Strategies, with emphasis on TENIS. Journal of Nuclear Medicine Technology. PMID 27493262 DOI: 10.2967/jnmt.116.177881 |
0.137 |
|
| 2011 |
Beriwal S, Macklis RM, Basu S. Preface Radiation Therapy Planning with PET. Pet Clinics. 6: xi. PMID 27156592 DOI: 10.1016/j.cpet.2011.03.002 |
0.136 |
|
| 2019 |
Pawaskar A, Basu S, Jahangiri P, Alavi A. In Vivo Molecular Imaging of Musculoskeletal Inflammation and Infection. Pet Clinics. 14: 43-59. PMID 30420221 DOI: 10.1016/j.cpet.2018.08.009 |
0.136 |
|
| 2021 |
Parghane RV, Bhandare M, Chaudhari V, Shrikhande SV, Ostwal V, Ramaswamy A, Talole S, Basu S. Surgical feasibility, Determinants and overall Efficacy assessment of Neoadjuvant PRRT with Lu-DOTATATE for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33637590 DOI: 10.2967/jnumed.120.258772 |
0.135 |
|
| 2013 |
Bural GG, Torigian DA, Basu S, Bozkurt MF, Houseni M, Alavi A. Atherosclerotic inflammatory activity in the aorta and its correlation with aging and gender as assessed by 18F-FDG-PET. Hellenic Journal of Nuclear Medicine. 16: 164-8. PMID 24137578 DOI: 10.1967/s002449910092 |
0.133 |
|
| 2016 |
Paul D, Ostwal V, Bose S, Basu S, Gupta S. Personalized treatment approach to gastroenteropancreatic neuroendocrine tumors: a medical oncologist's perspective. European Journal of Gastroenterology & Hepatology. PMID 27257869 DOI: 10.1097/MEG.0000000000000674 |
0.133 |
|
| 2021 |
Kalshetty A, Menon B, Rakshit S, Bhattacharjee A, Basu S. Correlation of lesional uptake parameters and ratios with miPSMA score and estimating normal physiological concentration: an exploratory analysis in mCRPC patients with Ga-PSMA-11 PET-CT. Journal of Nuclear Medicine Technology. PMID 34244223 DOI: 10.2967/jnmt.120.261289 |
0.133 |
|
| 2007 |
Mavi A, Cermik TF, Urhan M, Puskulcu H, Basu S, Yu JQ, Zhuang H, Czerniecki B, Alavi A. The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1266-72. PMID 17631558 DOI: 10.2967/jnumed.106.037440 |
0.133 |
|
| 2011 |
Ramani SK, Basu S, Parmar V, Gujral S, Bibte S. Second primary malignancy of breast in a patient of gastrointestinal stromal tumor presenting as fluoro-deoxyglucose-avid breast incidentaloma in fluoro-deoxyglucose-positron emission tomography. Journal of Cancer Research and Therapeutics. 7: 387-9. PMID 22044838 DOI: 10.4103/0973-1482.87031 |
0.132 |
|
| 2011 |
Basu S, Baghel NS. Intense FDG uptake in the spleen due to recent granulocyte-macrophage colony-stimulating factor administration: follow-up scan clarifying the situation. Journal of Cancer Research and Therapeutics. 7: 228-9. PMID 21768724 DOI: 10.4103/0973-1482.82933 |
0.131 |
|
| 2015 |
Basu S, Ranade R, Thapa P. Correlation and discordance of tumour proliferation index and molecular imaging characteristics and their implications for treatment decisions and outcome pertaining to peptide receptor radionuclide therapy in patients with advanced neuroendocrine tumour: developing a personalized model. Nuclear Medicine Communications. 36: 766-74. PMID 25920048 DOI: 10.1097/MNM.0000000000000321 |
0.13 |
|
| 2007 |
Basu S, Alavi A. Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 1297; author reply 1. PMID 17401027 DOI: 10.1200/JCO.2006.10.0123 |
0.128 |
|
| 2018 |
Parghane RV, Basu S. Bilateral orbital soft tissue metastases from Renal Neuroendocrine Tumor: successful Theranostic application of Ga/Lu-DOTATATE with improvement of vision. Journal of Nuclear Medicine Technology. PMID 30139884 DOI: 10.2967/jnmt.118.217455 |
0.127 |
|
| 2011 |
Basu S, Yadav M, Joshi JM, Desai D, Moghe S. Active pre-treatment pure pulmonary parenchymal sarcoidosis with raised serum angiotensin converting enzyme level: characteristics on PET with glucose metabolism and cell proliferation tracers and HRCT. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1584-5. PMID 21380590 DOI: 10.1007/s00259-011-1756-6 |
0.126 |
|
| 2010 |
Mavi A, Cermik TF, Urhan M, Puskulcu H, Basu S, Cucchiara AJ, Yu JQ, Alavi A. The effect of age, menopausal state, and breast density on 18F-FDG uptake in normal glandular breast tissue Journal of Nuclear Medicine. 51: 347-352. PMID 20150253 DOI: 10.2967/jnumed.109.068718 |
0.125 |
|
| 2011 |
Basu S, Baghel NS. Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography. Japanese Journal of Radiology. 29: 291-2. PMID 21607846 DOI: 10.1007/s11604-010-0543-9 |
0.125 |
|
| 2021 |
Mitra A, Chakraborty A, Gaikwad S, Tawate M, Upadhye T, Lad S, Sahoo S, Jagesia P, Parghane R, Menon S, Basu S, Dhami PS, Banerjee S. On the Separation of Yttrium-90 from High-Level Liquid Waste: Purification to Clinical-Grade Radiochemical Precursor, Clinical Translation in Formulation of Y-DOTATATE Patient Dose. Cancer Biotherapy & Radiopharmaceuticals. 36: 143-159. PMID 33750229 DOI: 10.1089/cbr.2020.4092 |
0.125 |
|
| 2014 |
Basu S, Joshi A. (99m)Tc HYNIC-TOC imaging and 177Lu DOTA-octreotate treatment in non-iodine-concentrating dedifferentiated thyroid carcinoma metastases: an unusual alternative diagnosis. Clinical Nuclear Medicine. 39: 632-4. PMID 24873792 DOI: 10.1097/RLU.0000000000000461 |
0.124 |
|
| 2017 |
Basu S, Kalshetty A. Volumetric high-resolution computed tomography in evaluating pulmonary metastases from differentiated thyroid carcinoma: considerations for evolving the optimal diagnostic pathway. Nuclear Medicine Communications. 38: 881-882. PMID 28902716 DOI: 10.1097/MNM.0000000000000722 |
0.122 |
|
| 2013 |
Joshi J, Barve K, Basu S. Fluorodeoxyglucose positron emission tomography in tropical pulmonary eosinophilia presenting as interstitial lung disease Indian Journal of Allergy, Asthma and Immunology. 27: 52. DOI: 10.4103/0972-6691.116610 |
0.122 |
|
| 2009 |
Basu S. On the herpolhode Satyendra Nath Bose: His Life and Times. 7-8. DOI: 10.1142/9789812790729_0001 |
0.12 |
|
| 1994 |
Basu S. Foreword Radio Science. 29: 155-155. DOI: 10.1029/93RS02120 |
0.12 |
|
| 2017 |
Naik C, Basu S. Low grade mucoepidermoid tumor of Parotid gland presenting as focal asymmetry in the follow-up Radioiodine scan in a patient of differentiated papillary carcinoma of thyroid. Journal of Nuclear Medicine Technology. PMID 28408701 DOI: 10.2967/jnmt.117.190777 |
0.119 |
|
| 2020 |
Basu S, Ranade R, Abhyankar A. "Tumour sink effect" on the diagnostic or posttreatment radioiodine scan due to sequestration into large-volume functioning metastasis of differentiated thyroid carcinoma influencing uptake in smaller metastatic sites or remnant thyroid tissue: An uncommon but possible phenomenon in thyroid cancer practice. World Journal of Nuclear Medicine. 19: 141-143. PMID 32939202 DOI: 10.4103/wjnm.WJNM_54_19 |
0.118 |
|
| 2014 |
Basu S, Mahajan A. Discordant and aggressive tumor biology of solitary scalp metastasis amidst widespread skeletal metastases in differentiated thyroid carcinoma: Functional radionuclide and MR imaging features and clinical correlates Indian Journal of Cancer. 51: 613-614. DOI: 10.4103/0019-509X.175309 |
0.118 |
|
| 2009 |
Basu S. Functional imaging of brown adipose tissue with PET: can this provide new insights into the pathophysiology of obesity and thereby direct antiobesity strategies? Nuclear Medicine Communications. 29: 931-3. PMID 18836369 DOI: 10.1097/MNM.0b013e328310af46 |
0.116 |
|
| 2018 |
Suman S, Basu S. Solitary Metacarpophalangeal Metastasis from Poorly Differentiated Thyroid Carcinoma: Excellent Tumor Marker and Scan Response to Two Fractions of Radioiodine Therapy. Indian Journal of Nuclear Medicine : Ijnm : the Official Journal of the Society of Nuclear Medicine, India. 33: 362-363. PMID 30386065 DOI: 10.4103/ijnm.IJNM_86_18 |
0.116 |
|
| 2011 |
Rachh SH, Abhyankar S, Basu S. [131I]Metaiodobenzylguanidine therapy in neural crest tumors: Varying outcome in different histopathologies Nuclear Medicine Communications. 32: 1201-1210. PMID 21968432 DOI: 10.1097/MNM.0b013e32834bad97 |
0.116 |
|
| 2020 |
Parghane RV, Ostwal V, Ramaswamy A, Bhandare M, Chaudhari V, Talole S, Shrikhande SV, Basu S. Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32876706 DOI: 10.1007/s00259-020-05004-5 |
0.114 |
|
| 2015 |
Basu S. Hypothesizing association between cancer cachexia and Fluorodeoxyglucose-positron emission tomography documented brown adipose tissue hypermetabolism in cancer patients with an illustration in grossly emaciated cachectic patient in hot Indian summer climate: Will beta blockers find use in the management of this condition? Indian Journal of Cancer. 52: 223-4. PMID 26853413 DOI: 10.4103/0019-509X.175828 |
0.114 |
|
| 2008 |
Basu S, Asopa R, Peshwe H, Mohandas KM. Diffuse intense FDG uptake in the bone marrow in gastrointestinal stromal tumor with coexistent polycythemia rubra vera. Clinical Nuclear Medicine. 33: 782-3. PMID 18936614 DOI: 10.1097/RLU.0b013e318187ef9b |
0.113 |
|
| 2019 |
Adnan A, Basu S. Rare Site Primary Soft tissue Neuroendocrine Tumour with metastases and near-complete resolution with Lu-DOTATATE: documenting a Promising Clinical Application of Peptide Receptor Radionuclide Therapy. Journal of Nuclear Medicine Technology. PMID 31401619 DOI: 10.2967/jnmt.119.227058 |
0.113 |
|
| 2012 |
Kwee TC, Basu S, Saboury B, Alavi A, Torigian DA. Functional oncoimaging techniques with potential clinical applications Frontiers in Bioscience - Elite. 4: 1081-1096. PMID 22201938 DOI: 10.2741/443 |
0.113 |
|
| 2004 |
Basu S, Nair N, Awasare S, Tiwari BP, Asopa R, Nair C. 99Tcm(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: Diagnosis, treatment monitoring and therapeutic implications British Journal of Radiology. 77: 347-361. PMID 15107330 DOI: 10.1259/bjr/72600472 |
0.111 |
|
| 2017 |
Parghane RV, Talole S, Prabhash K, Basu S. Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Clinical Nuclear Medicine. PMID 28319500 DOI: 10.1097/RLU.0000000000001639 |
0.11 |
|
| 2014 |
Ranade R, Rachh S, Basu S. Late Manifestation of Peritoneal strumosis and widespread functioning lesions in the setting of Struma Ovarii simulating "Highly Differentiated Follicular Carcinoma" (HDFCO). Journal of Nuclear Medicine Technology. PMID 25537757 DOI: 10.2967/jnmt.114.149294 |
0.11 |
|
| 2007 |
Basu S, Alavi A. Avid FDG uptake in the right ventricle coupled with enhanced intercostal muscle hypermetabolism in pneumoconiosis. Clinical Nuclear Medicine. 32: 407-8. PMID 17452877 DOI: 10.1097/01.RLU.0000259624.76063.65 |
0.109 |
|
| 2011 |
Basu S, Abhyankar A, Kand P, Kumar R, Asopa R, Rajan MG, Nayak U, Shimpi H, Das T, Venkatesh M, Chakrabarty S, Banerjee S. 'Reverse discordance' between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan: the plausible explanations and its implications for high-dose therapy with radiolabeled somatostatin receptor analogs. Nuclear Medicine Communications. 32: 654-8. PMID 21654355 DOI: 10.1097/MNM.0b013e328346350f |
0.108 |
|
| 2014 |
Tiwari BP, Nistala S, Patil SP, Kalgutkar DP, Jaychandran N, Chander H, Basu S. Evaluation of the (14)C-urea breath test using indigenously produced (14)C-urea capsules and a modified technique for trapping exhaled breath: a pilot study. Nuclear Medicine Communications. 35: 325-30. PMID 24284990 DOI: 10.1097/MNM.0000000000000043 |
0.108 |
|
| 2015 |
Thapa P, Joshi S, Basu S. Midline or near-midline radioiodine uptake in the oropharyngeal region in patients of differentiated thyroid carcinoma: Differential diagnosis between lingual thyroid and retropharyngeal nodal metastasis, the subtle clues in the scan and their implications for patient management. South Asian Journal of Cancer. 4: 98-9. PMID 25992352 DOI: 10.4103/2278-330X.155700 |
0.106 |
|
| 2001 |
Basu S, Nair N, Aravind N. Unilateral proptosis with thyrotoxicosis resulting from solitary retroorbital soft tissue metastasis from follicular carcinoma thyroid. Clinical Nuclear Medicine. 26: 136-8. PMID 11201471 DOI: 10.1097/00003072-200102000-00009 |
0.104 |
|
| 1995 |
Basu S. Ranges of posterior probability over a distribution band Journal of Statistical Planning and Inference. 44: 149-166. DOI: 10.1016/0378-3758(94)00048-Z |
0.104 |
|
| 2015 |
Menon BK, Basu S. Relevance of a thyroid phantom in estimating thyroid radioiodine uptake values using a gamma camera. Nuclear Medicine Communications. PMID 25932539 DOI: 10.1097/MNM.0000000000000335 |
0.104 |
|
| 1999 |
Basu S. Posterior sensitivity to the sampling distribution and the prior: More than one observation Annals of the Institute of Statistical Mathematics. 51: 499-513. |
0.104 |
|
| 2021 |
Jha A, Taieb D, Carrasquillo JA, Pryma DA, Patel M, Millo C, de Herder WW, Del Rivero J, Crona J, Shulkin BL, Virgolini I, Chen AP, Mittal BR, Basu S, Dillon JS, et al. High-specific-activity I-MIBG vs Lu-DOTATATE targeted radionuclide therapy for metastatic pheochromocytoma and paraganglioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33685867 DOI: 10.1158/1078-0432.CCR-20-3703 |
0.104 |
|
| 2006 |
Basu S, Nair N, Shet T, Borges AM. Papillary thyroid carcinoma with exuberant nodular fasciitis-like stroma: Treatment outcome and prognosis Journal of Laryngology and Otology. 120: 338-342. PMID 16623982 DOI: 10.1017/S0022215106000211 |
0.103 |
|
| 2014 |
Menon BK, Rao RD, Abhyankar A, Rajan MG, Basu S. Comparative evaluation of 24-hour thyroid 131I uptake between γ camera-based method using medium-energy collimator and standard uptake probe-based method. Journal of Nuclear Medicine Technology. 42: 194-7. PMID 24970896 DOI: 10.2967/jnmt.114.139162 |
0.102 |
|
| 2013 |
Joseph JK, Patel RB, Damle AA, Nair N, Badwe RA, Basu S. Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study. Indian Journal of Surgical Oncology. 4: 80-91. PMID 24426705 DOI: 10.1007/s13193-012-0205-8 |
0.101 |
|
| 2016 |
Thapa P, Ranade R, Ostwal V, Shrikhande SV, Goel M, Basu S. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics. Nuclear Medicine Communications. PMID 27243215 DOI: 10.1097/MNM.0000000000000547 |
0.101 |
|
| 2012 |
Basu S, Mahajan A. Extensive 99mTc-MDP uptake in metastasis to contralateral pleura from osteosarcoma of femur: an indirect measure of extent of disease involvement at diagnosis. Journal of Cancer Research and Therapeutics. 8: 655-6. PMID 23361297 DOI: 10.4103/0973-1482.106594 |
0.101 |
|
| 2018 |
Kalshetty A, Basu S. Thyroglobulin "Nonsecretor" Metastatic Poorly Differentiated Thyroid Carcinoma with Noniodine Concentrating Disease and Aggressive Clinical Course: A Clinical Case Series. Indian Journal of Nuclear Medicine : Ijnm : the Official Journal of the Society of Nuclear Medicine, India. 33: 218-223. PMID 29962718 DOI: 10.4103/ijnm.IJNM_45_18 |
0.099 |
|
| 2012 |
Basu S, Borde CR, Abhyankar A. Advantages of surgical extirpation in addition to radioiodine therapy in differentiated thyroid carcinoma patients with a solitary large-volume skeletal metastasis with small-volume oligometastatic disease in the rest of the whole body. Journal of Cancer Research and Therapeutics. 8: 656-7. PMID 23361298 DOI: 10.4103/0973-1482.106595 |
0.098 |
|
| 2014 |
Rani D, Kaisar S, Awasare S, Kamaldeep, Abhyankar A, Basu S. Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1767-80. PMID 24687139 DOI: 10.1007/s00259-014-2737-3 |
0.095 |
|
| 2006 |
Basu S, Nair N. Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzylguanidine (MIBG) therapy in metastatic paediatric paraganglioma: observation on false "reverse" discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy The British Journal of Radiology.. 79. PMID 16861319 DOI: 10.1259/BJR/27645093 |
0.095 |
|
| 2015 |
Chouhan A, Abhyankar A, Basu S. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study. Nuclear Medicine Communications. PMID 26465804 DOI: 10.1097/MNM.0000000000000414 |
0.093 |
|
| 2019 |
Thapa P, Basu S. Leveraging the power of non-radium radionuclide treatments in bone metastases. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 31271269 DOI: 10.23736/S1824-4785.19.03177-7 |
0.093 |
|
| 2018 |
Ramesh S, Kudachi S, Basu S. PRRT with Lu-DOTATATE in Carcinoid Heart Disease: a contraindication or a promising treatment approach bettering chances for corrective surgery? Journal of Nuclear Medicine Technology. PMID 29884687 DOI: 10.2967/jnmt.118.210179 |
0.092 |
|
| 2011 |
Kwee TC, Basu S, Torigian DA, Saboury B, Alavi A. Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: Evolving contribution of PET in this setting European Journal of Nuclear Medicine and Molecular Imaging. 38: 1353-1366. PMID 21225421 DOI: 10.1007/s00259-010-1717-5 |
0.092 |
|
| 2014 |
Basu S, Sirohi B, Shrikhande SV. Dual tracer imaging approach in assessing tumor biology and heterogeneity in neuroendocrine tumors: its correlation with tumor proliferation index and possible multifaceted implications for personalized clinical management decisions, with focus on PRRT. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1492-6. PMID 24863431 DOI: 10.1007/s00259-014-2805-8 |
0.092 |
|
| 2020 |
Kamaldeep, Wanage G, Sahu SK, Maletha P, Adnan A, Suman S, Basu S, Das T, Banerjee S. Examining Absorbed Doses of Indigenously Developed Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy. Cancer Biotherapy & Radiopharmaceuticals. PMID 32379495 DOI: 10.1089/cbr.2020.3640 |
0.091 |
|
| 2019 |
Parghane RV, Naik C, Talole S, Desmukh A, Chaukar D, Banerjee S, Basu S. Clinical utility of Lu-DOTATATE PRRT in somatostatin receptor-positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity. Head & Neck. PMID 31755622 DOI: 10.1002/hed.26024 |
0.09 |
|
| 2013 |
Basu S. Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 2018-9. PMID 24071506 DOI: 10.2967/jnumed.113.127829 |
0.09 |
|
| 2019 |
Adnan A, Kudachi S, Ramesh S, Prabhash K, Basu S. Metastatic or locally advanced mediastinal neuroendocrine tumours: outcome with 177Lu-DOTATATE-based peptide receptor radionuclide therapy and assessment of prognostic factors. Nuclear Medicine Communications. PMID 31343606 DOI: 10.1097/MNM.0000000000001054 |
0.09 |
|
| 2014 |
Gandhi S, Abhyankar A, Basu S. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables. Nuclear Medicine Communications. 35: 205-9. PMID 24217429 DOI: 10.1097/MNM.0000000000000033 |
0.088 |
|
| 2013 |
Basu S, Pantvaidya G, Malvadkar S. Excellent response to combined radioiodine and enoxaparin in the setting of tumor venous thrombosis from differentiated thyroid carcinoma involving internal jugular and subclavian veins. Future Oncology (London, England). 9: 1813-8. PMID 24295411 DOI: 10.2217/fon.13.162 |
0.088 |
|
| 2012 |
Mitra D, Basu S. Equilibrium radionuclide angiocardiography: Its usefulness in current practice and potential future applications. World Journal of Radiology. 4: 421-30. PMID 23150766 DOI: 10.4329/wjr.v4.i10.421 |
0.088 |
|
| 2010 |
Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian Journal of Nuclear Medicine : Ijnm : the Official Journal of the Society of Nuclear Medicine, India. 25: 135-8. PMID 21713220 DOI: 10.4103/0972-3919.78245 |
0.088 |
|
| 2013 |
Basu S, Mahajan A. Ovarian dermoid cyst serendipitously detected by pelvic radioiodine-(131)I uptake and by diffusion weighted MRI in a post-thyroidectomy case of papillary thyroid carcinoma. Hellenic Journal of Nuclear Medicine. 16: 62-3. PMID 23529395 DOI: 10.1967/s002449910073 |
0.086 |
|
| 2020 |
Parghane RV, Talole S, Basu S. I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with Lu-DOTATATE peptide receptor radionuclide therapy. Annals of Nuclear Medicine. PMID 33135123 DOI: 10.1007/s12149-020-01541-z |
0.086 |
|
| 1987 |
Basu S. Image Segmentation by semantic method Pattern Recognition. 20: 497-511. DOI: 10.1016/0031-3203(87)90077-X |
0.085 |
|
| 1980 |
Basu S. Detection of cathodoluminescence of Giemsa stain and its applications Review of Scientific Instruments. 51: 435-439. PMID 7367800 DOI: 10.1063/1.1136241 |
0.085 |
|
| 2016 |
Chakraborty A, Kane S, Pawar Y, Basu S. Classical Papillary Thyroid Carcinoma with Multiple Recurrences gradually evolving into Tall Cell Variant and TENIS: Histopathology, Imaging Characteristics and Documentation of BRAF V600E along with a Rare BRAF I582M Mutation. Journal of Nuclear Medicine Technology. PMID 27834723 DOI: 10.2967/jnmt.116.181396 |
0.085 |
|
| 2007 |
Basu S, Alavi A. Defining co-related parameters between 'metabolic' flare and 'clinical', 'biochemical', and 'osteoblastic' flare and establishing guidelines for assessing response to treatment in cancer. European Journal of Nuclear Medicine and Molecular Imaging. 34: 441-3. PMID 17072613 DOI: 10.1007/s00259-006-0264-6 |
0.085 |
|
| 2016 |
Basu S. Bilateral axillary and infrahilar nodal metastases in follicular variant of papillary thyroid carcinoma (transformed into poorly differentiated subtype) in the setting of elevated thyroglobulin and negative radioiodine scintigraphy. Journal of Cancer Research and Therapeutics. 12: 423-4. PMID 27072275 DOI: 10.4103/0973-1482.172136 |
0.083 |
|
| 2009 |
Basu S. Selecting the optimal image segmentation strategy in the era of multitracer multimodality imaging: a critical step for image-guided radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. 36: 180-1. PMID 19130055 DOI: 10.1007/s00259-008-1033-5 |
0.083 |
|
| 2012 |
Kwee TC, Basu S, Torigian DA, Nievelstein RA, Alavi A. Evolving Importance of Diffusion-Weighted Magnetic Resonance Imaging in Lymphoma. Pet Clinics. 7: 73-82. PMID 27157020 DOI: 10.1016/j.cpet.2011.11.001 |
0.082 |
|
| 2018 |
Adnan A, Deep K, Kameswaran M, Nikam D, Chandrakala S, Dash A, Banerjee S, Basu S. Biodistribution and Dosimetry of Indigenous I-Rituximab in B-Cell Lymphoma: Pilot Study estimating patient specific dose comparing two different dosimetric methods. Journal of Nuclear Medicine Technology. PMID 30413603 DOI: 10.2967/jnmt.118.216754 |
0.08 |
|
| 2015 |
Basu S, Shet T. Bone-confined extensive disease as the presentation of disease recurrence in the setting of malignant transformation of pleomorphic adenoma of parotid gland with excellent locoregional control: Value of whole body skeletal survey. Indian Journal of Cancer. 52: 248-9. PMID 26853423 DOI: 10.4103/0019-509X.175833 |
0.079 |
|
| 2009 |
Basu S, Moghe SH, Shet T. Metastasis of humeral osteosarcoma to the contralateral breast detected by 99mTc-MDP skeletal scintigraphy. Japanese Journal of Radiology. 27: 455-7. PMID 20035419 DOI: 10.1007/s11604-009-0364-x |
0.079 |
|
| 2018 |
Kalshetty A, Ramaswamy A, Ostwal V, Basu S. Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting. Nuclear Medicine Communications. PMID 30308585 DOI: 10.1097/MNM.0000000000000926 |
0.079 |
|
| 2018 |
Naik C, Basu S. 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Borderline Low and Discordant Renal Parameters: Treatment Feasibility Assessment by Sequential Estimation of Triple Parameters and Filtration Fraction. World Journal of Nuclear Medicine. 17: 12-20. PMID 29398960 DOI: 10.4103/wjnm.WJNM_94_16 |
0.078 |
|
| 2012 |
Basu S, Abhyankar A. Adding surgery as a complementary approach to radioiodine therapy in patients of differentiated thyroid carcinoma with large solitary flat bone metastases: the unresolved issues. Journal of Surgical Oncology. 105: 622. PMID 22006471 DOI: 10.1002/jso.22116 |
0.078 |
|
| 2021 |
Mitra A, Chakraborty A, Upadhye T, Verma P, Rajesh C, Lad S, Pawar Y, Basu S, Banerjee S. Clinical efficacy of Sep-Pak® assisted one pot automated synthesis of pharmaceutical grade [18F]FLT using 5′-O-(benzoyl)-2,3′-anhydrothymidine precursor Journal of Radioanalytical and Nuclear Chemistry. 327: 585-596. DOI: 10.1007/s10967-020-07531-9 |
0.078 |
|
| 2016 |
Ranade R, Basu S. 177Lu-DOTATATE based PRRT in patients of Metastatic Neuroendocrine tumor with single functioning kidney: Evaluation of tolerability and effect on Renal Function Parameters. Journal of Nuclear Medicine Technology. PMID 26848166 DOI: 10.2967/jnmt.115.168146 |
0.076 |
|
| 2021 |
Basu S, Dong Y, Kumar R, Jeter C, Tang DG. Slow-Cycling (Dormant) Cancer Cells in Therapy Resistance, Cancer Relapse and Metastasis. Seminars in Cancer Biology. PMID 33979674 DOI: 10.1016/j.semcancer.2021.04.021 |
0.076 |
|
| 2015 |
Bural G, Torigian D, Basu S, Houseni M, Zhuge Y, Rubello D, Udupa J, Alavi A. Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain. Nuclear Medicine Communications. 36: 1249-52. PMID 26426967 DOI: 10.1097/Mnm.0000000000000394 |
0.075 |
|
| 2015 |
Basu S, Dandekar M, Joshi A, D'Cruz A. Defining a rational step-care algorithm for managing thyroid carcinoma patients with elevated thyroglobulin and negative on radioiodine scintigraphy (TENIS): considerations and challenges towards developing an appropriate roadmap. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1167-71. PMID 25989850 DOI: 10.1007/s00259-015-3058-x |
0.074 |
|
| 2016 |
Basu S, Ostwal V. The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27542673 DOI: 10.1007/s00259-016-3497-z |
0.074 |
|
| 2023 |
Basak D, Mondal S, Srivastava SK, Sarkar D, Sarkar I, Basu S, Bhoumik A, Chowdhury S, Pal DK, Chatterjee S. Intratumoral PD1CD38Tim3 CD8 T Cells in Pre-BCG Tumor Tissues Are Associated with Poor Responsiveness to BCG Immunotherapy in Patients with Non-Muscle Invasive Bladder Cancer. Cells. 12. PMID 37566017 DOI: 10.3390/cells12151939 |
0.071 |
|
| 2019 |
Basu S, Parghane R, Ranade R, Thapa P, Ramaswamy A, Ostwal V, Sirohi B, Panda D, Shrikhande S. Peptide receptor radionuclide therapy in the management of neuroendocrine tumors (Neoplasms)*: Fundamentals and salient clinical practice points for medical oncologists Indian Journal of Medical and Paediatric Oncology. 40: 165. DOI: 10.4103/ijmpo.ijmpo_161_19 |
0.069 |
|
| 2018 |
Parghane RV, Basu S. Large cardiac metastasis from pancreatic neuroendocrine tumor and response to peptide receptor radionuclide therapy with Lu-DOTATATE. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 30151794 DOI: 10.1007/s12350-018-1426-1 |
0.069 |
|
| 2018 |
Basu S, Parghane RV, Ostwal V, Shrikhande SV. Neoadjuvant strategies for advanced pancreatic neuroendocrine tumors: should combined chemotherapy and peptide receptor radionuclide therapy be the preferred regimen for maximizing outcome? Nuclear Medicine Communications. 39: 94-95. PMID 29206780 DOI: 10.1097/MNM.0000000000000776 |
0.067 |
|
| 1951 |
Basu S. Viscosity of sodium thymonucleate Nature. 168: 341-342. DOI: 10.1038/168341A0 |
0.066 |
|
| 2012 |
Alavi A, Saboury B, Basu S. Imaging the infected heart. Science Translational Medicine. 3: 99fs3. PMID 21900589 DOI: 10.1126/scitranslmed.3003044 |
0.066 |
|
| 2008 |
Basu S, Torigian D, Alavi A. The role of modern molecular imaging techniques in gastroenterology. Gastroenterology. 135: 1055-61. PMID 18775712 DOI: 10.1053/j.gastro.2008.08.038 |
0.065 |
|
| 1990 |
Basu S. On Boundary Implications of Stability and Positivity Properties of Multidimensional Systems Proceedings of the Ieee. 78: 614-626. DOI: 10.1109/5.54802 |
0.065 |
|
| 2019 |
Dhingra VK, Pradhan PK, Garg N, Basu S. The feasibility and safety of graded adenosine stress test for myocardial perfusion in asthmatic and/or COPD patients. Hellenic Journal of Nuclear Medicine. PMID 31273356 DOI: 10.1967/s002449911007 |
0.064 |
|
| 1979 |
Basu S. Exciplex emission for hydrocarbon-dimethylaniline systems in hydroxylic solvents Journal of Photochemistry. 11: 9-13. DOI: 10.1016/0047-2670(79)85002-9 |
0.063 |
|
| 2012 |
Basu S. Benefit of treating patients of subclinical hypothyroidism with subfertility: Anecdotal observation or true association? American Journal of Medicine. 125. PMID 22340939 DOI: 10.1016/j.amjmed.2011.07.042 |
0.063 |
|
| 2020 |
Basu S, Kalshetty A. Sub-segmentation specific paradigms for better individualized management of poorly differentiated thyroid carcinoma: can a systematic approach be evolved? Nuclear Medicine Communications. 41: 1-4. PMID 31800506 DOI: 10.1097/MNM.0000000000001100 |
0.062 |
|
| 2007 |
Basu S. Chemical and biochemical processes for Nox control from combustion off-gases Chemical Engineering Communications. 194: 1374-1395. DOI: 10.1080/00986440701401537 |
0.061 |
|
| 2019 |
Basu S, Parghane RV, Banerjee S. Availability of both [Lu]Lu-DOTA-TATE and [Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors? European Journal of Nuclear Medicine and Molecular Imaging. PMID 31628515 DOI: 10.1007/s00259-019-04546-7 |
0.061 |
|
| 2011 |
Basu S, Moghe SH. Displaced left kidney masquerading as splenic blush in 99mTc-DTPA GFR study in a patient of paravertebral primitive neuroectodermal tumor. Journal of Cancer Research and Therapeutics. 7: 97-8. PMID 21546756 DOI: 10.4103/0973-1482.80454 |
0.061 |
|
| 2021 |
Basu S, Thirumalaiselvi A, Sasmal S, Kundu T. Nonlinear ultrasonics-based technique for monitoring damage progression in reinforced concrete structures. Ultrasonics. 115: 106472. PMID 34058636 DOI: 10.1016/j.ultras.2021.106472 |
0.06 |
|
| 1965 |
Basu S. Free electron model and magnetic susceptibility of aromatic hydrocarbons Theoretica Chimica Acta. 3: 156-158. DOI: 10.1007/BF00527346 |
0.06 |
|
| 2004 |
Basu S. Quantitative evaluation of bone metastases in patients with advanced prostate cancer during systemic treatment [4] Bju International. 93: 889. PMID 15050018 |
0.06 |
|
| 2016 |
Basu S, Banerjee S. Developing a dedicated comprehensive α-radionuclide therapy program: should this be the vision of the atomic energy programs in the next decade? Nuclear Medicine Communications. PMID 27906780 DOI: 10.1097/MNM.0000000000000626 |
0.06 |
|
| 1973 |
Basu S. Chemotherapy in malignant lymphadenopathy Calcutta Medical Journal. 70: 86-91. |
0.059 |
|
| 2000 |
Basu S. On sets with Baire property in topological spaces Czechoslovak Mathematical Journal. 50: 59-65. DOI: 10.1023/A:1022485002806 |
0.057 |
|
| 1996 |
Basu S. Existence of a normal scale mixture with a given variance and a percentile Statistics and Probability Letters. 28: 115-120. DOI: 10.1016/0167-7152(95)00104-2 |
0.056 |
|
| 2013 |
Basu S, Kand P, Mallia M, Korde A, Shimpi H. Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting. European Journal of Nuclear Medicine and Molecular Imaging. 40: 1622-4. PMID 23857460 DOI: 10.1007/s00259-013-2501-0 |
0.056 |
|
| 2010 |
Basu S. Dose fractionation in 131I-metaiodobenzylguanidine (MIBG) therapy: should the tumour biology and intent of therapy be the guide? European Journal of Nuclear Medicine and Molecular Imaging. 37: 1798-9. PMID 20596864 DOI: 10.1007/s00259-010-1530-1 |
0.056 |
|
| 2011 |
Basu S, Viswanathan S. Primary paraganglioma of thyroid presenting as solitary thyroid mass. Journal of Cancer Research and Therapeutics. 7: 385-7. PMID 22044837 DOI: 10.4103/0973-1482.87028 |
0.055 |
|
| 2009 |
Basu S. Can the dynamic eddy-viscosity class of subgrid-scale models capture inertial-range properties of Burgers turbulence? Journal of Turbulence. 10. DOI: 10.1080/14685240902852719 |
0.055 |
|
| 2017 |
Basu S, Abhyankar A. Short course of oral lithium therapy as an adjunct in patients with thyrotoxicosis who failed initial radioiodine therapy: should this be worthwhile to consider in the absence of contraindications? Nuclear Medicine Communications. 38: 726-727. PMID 28700404 DOI: 10.1097/MNM.0000000000000704 |
0.055 |
|
| 1987 |
Basu S, Fettweis A. New results on stable multidimensional polynomials—part ii: Discrete case Ieee Transactions On Circuits and Systems. 34: 1264-1274. DOI: 10.1109/TCS.1987.1086065 |
0.055 |
|
| 1999 |
Basu S. Conservatism of the z confidence interval under symmetric and asymmetric departures from normality Annals of the Institute of Statistical Mathematics. 51: 217-230. |
0.055 |
|
| 1984 |
Basu S. ACCELERATED CAVITATION SCREENING OF ORGANIC COATINGS USING ACOUSTIC EMISSION TECHNIQUE Journal of Vibration, Acoustics, Stress, and Reliability in Design. 106: 560-564. |
0.055 |
|
| 2018 |
Deshmukh A, Gangiti K, Pantvaidya G, Nair D, Basu S, Chaukar D, Pai P, Nair S, Hawaldar R, Dusane R, Chaturvedi P, D'Cruz A. Surgical outcomes of thyroid cancer patients in a tertiary cancer center in India. Indian Journal of Cancer. 55: 23-32. PMID 30147089 DOI: 10.4103/ijc.IJC_528_17 |
0.054 |
|
| 2020 |
Sitani K, Parghane RV, Talole S, Basu S. Long-term outcome of indigenous Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care setting. The British Journal of Radiology. 20201041. PMID 33095671 DOI: 10.1259/bjr.20201041 |
0.054 |
|
| 2009 |
Basu S, Shet T, Borges AM. Outcome of primary papillary carcinoma of thyroglossal duct cyst with local infiltration to soft tissues and uninvolved thyroid Indian Journal of Cancer. 46: 169-170. PMID 19346653 DOI: 10.4103/0019-509X.49157 |
0.054 |
|
| 2015 |
Basu S, Abhyankar A, Jatale P. The current place and indications of 131I-metaiodobenzylguanidine therapy in the era of peptide receptor radionuclide therapy: determinants to consider for evolving the best practice and envisioning a personalized approach. Nuclear Medicine Communications. 36: 1-7. PMID 25299467 DOI: 10.1097/MNM.0000000000000209 |
0.053 |
|
| 1991 |
Basu S. Possibility of X-Ray Detection Using Quantum Wells Ieee Journal of Quantum Electronics. 27: 2116-2121. DOI: 10.1109/3.135169 |
0.053 |
|
| 2016 |
Basu S, Vadaie N, Prabhakar A, Li B, Adhikari H, Pitoniak A, Chow J, Chavel CA, Cullen PJ. Spatial landmarks regulate a Cdc42-dependent MAPK pathway to control differentiation and the response to positional compromise. Proceedings of the National Academy of Sciences of the United States of America. PMID 27001830 DOI: 10.1073/Pnas.1522679113 |
0.052 |
|
| 2013 |
Kwee TC, Cheng G, Lam MG, Basu S, Alavi A. SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions. European Journal of Nuclear Medicine and Molecular Imaging. 40: 1475-7. PMID 23801170 DOI: 10.1007/s00259-013-2484-x |
0.052 |
|
| 2002 |
Basu S. Computing the Betti numbers of arrangements Conference Proceedings of the Annual Acm Symposium On Theory of Computing. 712-720. |
0.052 |
|
| 2009 |
Basu S, Moghe SH. Unusual unilateral breast (131)I uptake related to breastfeeding practice. Clinical Radiology. 64: 743-4. PMID 19520222 DOI: 10.1016/j.crad.2009.02.014 |
0.052 |
|
| 2009 |
Basu S. Cancer molecular diagnostics take the stage CMDs are at the forefront of evolving healthcare practices Genetic Engineering and Biotechnology News. 29. |
0.052 |
|
| 2020 |
Loharkar S, Basu S. Case work-up and monitoring of systemic radionuclide therapies: A proposed 3-sheet excel format with integrated graph for implementation in a busy treatment set-up. World Journal of Nuclear Medicine. 19: 447-451. PMID 33623523 DOI: 10.4103/wjnm.WJNM_98_20 |
0.051 |
|
| 2001 |
Basu S. Wall effect in laminar flow of non-Newtonian fluid through a packed bed Chemical Engineering Journal. 81: 323-329. DOI: 10.1016/S1385-8947(00)00221-7 |
0.051 |
|
| 1982 |
Basu S. Formation of gunshot residues Journal of Forensic Sciences. 27: 72-91. |
0.05 |
|
| 2006 |
Basu S. Single phase active power factor correction converters methods for optimizing EMI, performance and costs Doktorsavhandlingar Vid Chalmers Tekniska Hogskola. 1-110. |
0.05 |
|
| 2023 |
Sasmal S, Basu S, Himakar CVV, Kundu T. Detection of interface flaws in Concrete-FRP composite structures using linear and nonlinear ultrasonics based techniques. Ultrasonics. 132: 107007. PMID 37121183 DOI: 10.1016/j.ultras.2023.107007 |
0.05 |
|
| 1950 |
Basu S. Study of the optical properties of shellac solutions: Depolarization of scattered light Journal of Physical and Colloid Chemistry. 54: 1358-1366. PMID 14804348 |
0.05 |
|
| 2015 |
Basu S. "Fraction", "Cycle" or a new terminology? What would be most appropriate for Molecular Targeted Radiotherapy with Unsealed Sources? Journal of Nuclear Medicine Technology. PMID 26338488 DOI: 10.2967/jnmt.115.164046 |
0.049 |
|
| 2017 |
Basu S, Abhyankar A. Response to: Oral lithium as an adjunctive therapy during radioiodine treatment for hyperthyroidism. Nuclear Medicine Communications. 38: 1133-1134. PMID 29140921 DOI: 10.1097/MNM.0000000000000763 |
0.047 |
|
| 2008 |
Basu S, Asopa R, Moghe SH. Diffuse bone marrow uptake of 99mTc (III) DMSA in Fanconi's anemia. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1402. PMID 18458900 DOI: 10.1007/s00259-008-0811-4 |
0.046 |
|
| 2001 |
Basu S. Different bounds on the different Betti numbers of semi-algebraic sets Proceedings of the Annual Symposium On Computational Geometry. 288-292. |
0.045 |
|
| 2020 |
Dhingra V, Dhingra M, Basu S. Nuclear Medicine from the past to the present: A brief story of its development, key impact areas in current times and its potential for the future Journal of Medical Evidence. 1: 26. DOI: 10.4103/jme.jme_71_20 |
0.045 |
|
| 2013 |
Basu S. A study of body mass index in the population and its association with blood pressure and serum levels of glucose and triacylglycerol International Journal of Pharma and Bio Sciences. 4. |
0.045 |
|
| 2018 |
Basu S, Parghane RV, Joshi A, Prabhash K, Banerjee S. The rationality of combining second-generation antiandrogens with 177Lu-PSMA or its alpha-emitting congeners for better and durable results: will this dominate the therapeutic landscape and be an upfront consideration in metastatic castration-resistant prostate cancer in the coming years? Nuclear Medicine Communications. PMID 30339554 DOI: 10.1097/MNM.0000000000000932 |
0.045 |
|
| 2014 |
Basu S. Satellite data assimilation in global forecast system in India Proceedings of Spie - the International Society For Optical Engineering. 9265. DOI: 10.1117/12.2074829 |
0.044 |
|
| 1991 |
Basu S. New Results on Stable Multidimensional Polynomials Part III: State-Space Interpretations Ieee Transactions On Circuits and Systems. 38: 755-768. DOI: 10.1109/31.135747 |
0.044 |
|
| 1985 |
Basu S. Cathodoluminescence studies: from chromatin and chromosome to human hair Progress in Clinical and Biological Research. 196: 265-288. PMID 4080726 |
0.044 |
|
| 2002 |
Basu S. On spectral factorization in two-dimensions Proceedings - Ieee International Symposium On Circuits and Systems. 3. |
0.044 |
|
| 2021 |
Rajamanickam S, Chaukar D, Siddiq S, Basu S, D'Cruz A. Quality of life comparison in thyroxine hormone withdrawal versus triiodothyronine supplementation prior to radioiodine ablation in differentiated thyroid carcinoma: a prospective cohort study in the Indian population. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. PMID 34165625 DOI: 10.1007/s00405-021-06948-6 |
0.043 |
|
| 2008 |
Basu S. Biogas as a source of energy from renewable resources Npra Environmental Conference Papers. 317-336. |
0.043 |
|
| 2016 |
Basu S. Looking through misogyny: Indian men's rights activists, law, and challenges for Feminism Canadian Journal of Women and the Law. 28: 45-58. DOI: 10.3138/cjwl.28.1.45 |
0.043 |
|
| 1997 |
Basu S. Evolution of subkilometer scale ionospheric irregularities generated by high-power HF waves Journal of Geophysical Research a: Space Physics. 102: 7469-7475. |
0.042 |
|
| 1991 |
Basu S. Fluorescence enhancement of tetrakis(sulfonatophenyl) porphyrin in homogeneous and micellar solutions Journal of Photochemistry and Photobiology, a: Chemistry. 56: 339-347. DOI: 10.1016/1010-6030(91)80033-E |
0.042 |
|
| 1991 |
Basu S. Magnetic field effect on the exciplex luminescence as a probe for estimating the hyperfine interaction in a radical ion pair system Proceedings of the Indian Academy of Sciences - Chemical Sciences. 103: 557-562. DOI: 10.1007/BF02874654 |
0.042 |
|
| 2019 |
Yuan Y, Basu S, Lin MH, Shukla S, Sarkar D. Colloidal Gels for Guiding Endothelial Cell Organization via Microstructural Morphology. Acs Applied Materials & Interfaces. PMID 31403768 DOI: 10.1021/acsami.9b11293 |
0.042 |
|
| 1999 |
Basu S. Discussion of international differences in the timeliness, conservatism, and classification of earnings Journal of Accounting Research. 37: 89-99. |
0.042 |
|
| 2000 |
Basu S. A constructive algorithm for 2-D spectral factorization with rational spectral factors Ieee Transactions On Circuits and Systems I: Fundamental Theory and Applications. 47: 1309-1318. DOI: 10.1109/81.883325 |
0.042 |
|
| 2015 |
Thapa P, Nikam D, Das T, Sonawane G, Agarwal JP, Basu S. Clinical evaluation of efficacy and safety of 177Lu-EDTMP in patients with Painful Skeletal Metastasis: a multiparametric comparison with 153Sm-EDTMP on equidose basis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26315829 DOI: 10.2967/jnumed.115.155762 |
0.041 |
|
| 1997 |
Basu S. Why institutional credit agencies are reluctant to lend to the rural poor: A theoretical analysis of the indian rural credit market World Development. 25: 267-280. |
0.041 |
|
| 1960 |
BASU S. Radiotherapy and the general practitioner Journal of the Indian Medical Association. 34: 13-16. PMID 13797467 |
0.041 |
|
| 1979 |
Basu S. Convergence Limit in the Electronic Spectra of Linear Polyenes Advances in Quantum Chemistry. 11: 33-49. DOI: 10.1016/S0065-3276(08)60233-6 |
0.04 |
|
| 2021 |
Weber M, Basu S, González B, Greslehner GP, Singer S, Haskova D, Hasek J, Breitenbach M, W Gourlay C, Cullen PJ, Rinnerthaler M. Actin Cytoskeleton Regulation by the Yeast NADPH Oxidase Yno1p Impacts Processes Controlled by MAPK Pathways. Antioxidants (Basel, Switzerland). 10. PMID 33671669 DOI: 10.3390/antiox10020322 |
0.04 |
|
| 2011 |
Kwee TC, Basu S, Saboury B, Torigian DA, Naji A, Alavi A. Beta-cell imaging: Opportunities and limitations Journal of Nuclear Medicine. 52: 493. DOI: 10.2967/jnumed.110.085530 |
0.04 |
|
| 1969 |
Basu S. The Role of DNA Concentration Zeitschrift Fur Naturforschung - Section B Journal of Chemical Sciences. 24: 511-514. PMID 4389790 DOI: 10.1515/znb-1969-0506 |
0.04 |
|
| 2002 |
Basu S. Initiating malaria control programs in the third world: Directives for short- and long-term solutions Journal of Health and Social Policy. 15: 59-75. PMID 12212933 DOI: 10.1300/J045V15N01_04 |
0.04 |
|
| 2006 |
Basu S, Nair N. Relapse of cervical cancer presenting as symptoms of Collet-Sicard syndrome with metastatic subcutaneous and adrenal deposits Lancet Oncology. 7: 610. PMID 16814215 DOI: 10.1016/S1470-2045(06)70764-1 |
0.039 |
|
| 1978 |
Basu S. Exciplex-aromatic complex formation Journal of Photochemistry. 9: 539-544. DOI: 10.1016/0047-2670(78)80169-5 |
0.039 |
|
| 2008 |
Basu S. Modern marine turbocharger developments Journal of the Institution of Engineers (India), Part Mr: Marine Engineering Division. 89: 25-37. |
0.039 |
|
| 2007 |
Basu S. A note from the editor-in-chief Ieee Transactions On Circuits and Systems I: Regular Papers. 54: 2341. DOI: 10.1109/TCSI.2007.908263 |
0.039 |
|
| 1983 |
Basu S. The relationship between earnings' yield, market value and return for NYSE common stocks. Further evidence Journal of Financial Economics. 12: 129-156. DOI: 10.1016/0304-405X(83)90031-4 |
0.039 |
|
| 1986 |
Basu S. A curiosity concerning non-negative quantum distribution functions Physics Letters A. 114: 303-305. DOI: 10.1016/0375-9601(86)90564-5 |
0.039 |
|
| 1998 |
Basu S. Effects of errors in the solar radius on helioseismic inferences Monthly Notices of the Royal Astronomical Society. 298: 719-728. DOI: 10.1046/J.1365-8711.1998.01690.X |
0.038 |
|
| 1975 |
Basu S. Mass screening of gastro-intestinal tract to detect carcinoma of stomach Journal of the Indian Medical Association. 64: 327-329. PMID 1184982 |
0.038 |
|
| 2013 |
Anjum SG, Xu W, Nikkholgh N, Basu S, Nie Y, Thomas M, Satyamurti M, Budnik BA, Ip YT, Veraksa A. Regulation of Toll signaling and inflammation by β-arrestin and the SUMO protease Ulp1. Genetics. 195: 1307-17. PMID 24077307 DOI: 10.1534/Genetics.113.157859 |
0.038 |
|
| 2013 |
Tiwari BP, Basu S. Estimation of sacroiliac joint index in normal subjects of various age groups: comparative evaluation of four different methods of quantification in skeletal scintigraphy. Nuclear Medicine Review. Central & Eastern Europe. 16: 26-30. PMID 23677760 DOI: 10.5603/NMR.2013.0005 |
0.038 |
|
| 2005 |
Basu S. The challenges of and potential solutions to the problem of the trafficking of women and children: An overview Race, Culture, Psychology, and Law. 225-236. DOI: 10.4135/9781452233536.n15 |
0.038 |
|
| 1985 |
Basu S. Maternal recognition of pregnancy--a review of the literature Nordisk Veterinaermedicin. 37: 57-79. PMID 3889830 |
0.038 |
|
| 1989 |
Basu S. Deregulation: small business access to the capital market - theoretical issues with special reference to Australian bank finance Australian Economic Papers. 28: 141-159. DOI: 10.1111/j.1467-8454.1989.tb00465.x |
0.038 |
|
| 2014 |
Basu S, Ostwal V, Ranade R, Panda D. Supportive measures and finer practice points in 177Lu-DOTATATE PRRT for NET: aiming for optimal disease management. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1916-7. PMID 25214639 DOI: 10.2967/jnumed.114.146282 |
0.037 |
|
| 2007 |
Basu S. Future directions of fuel cell science and technology Recent Trends in Fuel Cell Science and Technology. 356-365. DOI: 10.1007/978-0-387-68815-2_14 |
0.037 |
|
| 1999 |
Basu S. Study of nonlinear four-wave interactions Journal of Plasma Physics. 61: 771-784. |
0.037 |
|
| 2003 |
Basu S. Why do banks fail? International Review of Applied Economics. 17: 231-248. DOI: 10.1080/0269217032000090469 |
0.037 |
|
| 1975 |
Basu S. Molecular Arrangement of DNA in Nucleohistone Zeitschrift Fur Naturforschung - Section C Journal of Biosciences. 30: 575-585. PMID 129987 DOI: 10.1515/znc-1975-9-1005 |
0.036 |
|
| 2016 |
Pal S, Sen S, Das D, Basu S. Examining a hypothetical quantitative model for better approximation of culprit coronary artery and site of stenosis on 99mTc-sestamibi gated myocardial perfusion SPECT. Nuclear Medicine Communications. PMID 27258991 DOI: 10.1097/MNM.0000000000000551 |
0.036 |
|
| 1984 |
Basu S. A review of nonlinear optical organic materials Industrial and Engineering Chemistry Product Research and Development. 23: 183-186. |
0.036 |
|
| 1989 |
Basu S. Endogenous inhibition of arachidonic acid metabolism in the endometrium of the sheep Prostaglandins, Leukotrienes and Essential Fatty Acids. 35: 147-152. PMID 2496410 DOI: 10.1016/0952-3278(89)90116-6 |
0.036 |
|
| 1956 |
Basu S. Further free electron calculation on oxidation-reduction potentials Transactions of the Faraday Society. 52: 1175-1178. |
0.036 |
|
| 1996 |
Basu S. Procyclical productivity: Increasing returns or cyclical utilization? Quarterly Journal of Economics. 111: 719-751. DOI: 10.2307/2946670 |
0.036 |
|
| 1969 |
Basu S. Spectrophotometric Studies on Aggregation of Denatured DNA Zeitschrift Fur Naturforschung - Section B Journal of Chemical Sciences. 24: 106-109. PMID 4388860 DOI: 10.1515/znb-1969-0122 |
0.035 |
|
| 2007 |
Basu S. Modelling the solar interior Aip Conference Proceedings. 919: 1-23. DOI: 10.1063/1.2756781 |
0.035 |
|
| 2006 |
Basu S. Helioseismic evidence for mixing in the sun Eso Astrophysics Symposia. 2006: 284-287. DOI: 10.1007/978-3-540-34136-9_93 |
0.035 |
|
| 1982 |
Basu S. Probability operator of a harmonic oscillator Soviet Physics Journal. 25: 956-960. DOI: 10.1007/BF00891676 |
0.034 |
|
| 2020 |
Basu S, González B, Li B, Kimble G, Kozminski KG, Cullen PJ. Functions for Cdc42p BEM Adaptors in Regulating a Differentiation-Type MAP Kinase Pathway. Molecular Biology of the Cell. mbcE19080441. PMID 31940256 DOI: 10.1091/Mbc.E19-08-0441 |
0.034 |
|
| 2021 |
Prabhakar A, González B, Dionne H, Basu S, Cullen PJ. Spatiotemporal control of pathway sensors and cross-pathway feedback regulate a differentiation MAPK pathway in yeast. Journal of Cell Science. 134. PMID 34347092 DOI: 10.1242/jcs.258341 |
0.034 |
|
| 2002 |
Basu S. Multidimensional causal, stable, perfect reconstruction filter banks Ieee Transactions On Circuits and Systems I: Fundamental Theory and Applications. 49: 832-842. DOI: 10.1109/TCSI.2002.1010038 |
0.033 |
|
| 2021 |
Prabhakar A, Gonzalez B, Dionne H, Basu S, Cullen PJ. Spatiotemporal control of pathway sensors and cross-pathway feedback regulate a differentiation MAPK pathway in yeast. Journal of Cell Science. PMID 34240741 DOI: 10.1242/jcs.258341 |
0.033 |
|
| 2007 |
Basu S. A quantitative study of the chlorine atom concentration in plasma: A step to assess the use of chlorine as a reagent gas to increase the mercury removal efficiency of an electrostatic precipitator Aiche Annual Meeting, Conference Proceedings. |
0.033 |
|
| 1954 |
Basu S. Free electron treatment of the orientation of substituents in aromatic molecule The Journal of Chemical Physics. 22. |
0.033 |
|
| 2005 |
Basu S. Discussion - The effect of risk on price responses to unexpected earnings Journal of Accounting, Auditing and Finance. 20: 483-494. |
0.033 |
|
| 1959 |
Basu S. Some notes on the electron repelling property of alkyl groups The Journal of Chemical Physics. 30: 314-315. |
0.032 |
|
| 1995 |
Basu S, Itoh T, Maas SA. Quasi-Periodic Route to Chaos in a Microwave Doubler Ieee Microwave and Guided Wave Letters. 5: 224-226. DOI: 10.1109/75.392282 |
0.032 |
|
| 2003 |
Basu S. Ch. 31. Bayesian inference for the number of undetected errors Handbook of Statistics. 22: 1131-1150. DOI: 10.1016/S0169-7161(03)22033-2 |
0.032 |
|
| 1994 |
Basu S. Deregulation of the Australian banking sector: a theoretical perspective Australian Economic Papers. 33: 272-285. DOI: 10.1111/j.1467-8454.1994.tb00865.x |
0.032 |
|
| 2023 |
Gonz Lez B, Mirzaei M, Basu S, Prabhakar A, Cullen PJ. New Features Surrounding the Cdc42-Ste20 Module that Regulates MAP Kinase Signaling in Yeast. Biorxiv : the Preprint Server For Biology. PMID 36909494 DOI: 10.1101/2023.02.28.530426 |
0.032 |
|
| 1993 |
Basu S. A Study on Effect of Wetting on Mechanism of Coalescence in a Model Coalescer Journal of Colloid and Interface Science. 159: 68-76. DOI: 10.1006/jcis.1993.1298 |
0.032 |
|
| 1989 |
Basu S. On the Multidimensional Generalization of Robustness of Scattering Hurwitz Property of Complex Polynomials Ieee Transactions On Circuits and Systems. 36: 1159-1167. DOI: 10.1109/31.34661 |
0.031 |
|
| 2018 |
Norman KL, Shively CA, De La Rocha AJ, Mutlu N, Basu S, Cullen PJ, Kumar A. Inositol polyphosphates regulate and predict yeast pseudohyphal growth phenotypes. Plos Genetics. 14: e1007493. PMID 29939992 DOI: 10.1371/Journal.Pgen.1007493 |
0.031 |
|
| 2013 |
Basu S. Neurotransmitter dopamine regulates tumor growth Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 210. DOI: 10.1016/B978-0-12-800044-1.00189-6 |
0.031 |
|
| 2019 |
Nair SK, Basu S, Sen B, Lin MH, Kumar AN, Yuan Y, Cullen PJ, Sarkar D. Colloidal Gels with Tunable Mechanomorphology Regulate Endothelial Morphogenesis. Scientific Reports. 9: 1072. PMID 30705322 DOI: 10.1038/S41598-018-37788-W |
0.031 |
|
| 1960 |
Basu S. Ionization in seeded detonation waves Physics of Fluids. 3: 456-463. |
0.031 |
|
| 2023 |
González B, Mirzaei M, Basu S, Pujari AN, Vandermeulen MD, Prabhakar A, Cullen PJ. Turnover and Bypass of p21-Activated Kinase During Cdc42-Dependent MAPK Signaling in Yeast. The Journal of Biological Chemistry. 105297. PMID 37774975 DOI: 10.1016/j.jbc.2023.105297 |
0.031 |
|
| 2011 |
Basu S. Development and In vitro evaluation of protein loaded plga microspheres Pharma Research. 5: 184-192. |
0.031 |
|
| 2008 |
Basu S. Requirements for FDA approval Lecture Notes in Electrical Engineering. 12: 269. DOI: 10.1007/978-0-387-71809-5_25 |
0.031 |
|
| 1974 |
Basu S. Value of antihistamine drug prior to intravenous pyelography Indian Journal of Radiology. 28: 215-218. |
0.03 |
|
| 2003 |
Basu S. Stellar inversions Astrophysics and Space Science. 284: 153-164. DOI: 10.1023/A:1023223115165 |
0.03 |
|
| 2012 |
Basu S. Nuclear medicine, scientific publishing and the era of cost containment: what factors hold the key? European Journal of Nuclear Medicine and Molecular Imaging. 39: 1358-9. PMID 22526954 DOI: 10.1007/s00259-012-2111-2 |
0.03 |
|
| 1965 |
Basu S. Free electron model and photoionization of π-electrons from aromatic hydrocarbons Theoretica Chimica Acta. 3: 238-240. DOI: 10.1007/BF00527719 |
0.03 |
|
| 2005 |
Basu S. Treatment efficiency of wastewater from manufacturing processes Journal of the Institution of Engineers (India), Part Pr: Production Engineering Division. 86: 1-4. |
0.029 |
|
| 2020 |
Sirohi B, Barreto S, Shrikhande S, Bhandare M, Bal M, Chacko R, Bhatia V, Basu S, Thulkar S, Kaur T, Dhaliwal R, Rath G. Indian Council of Medical Research consensus document for the management of gastroenteropancreatic neuroendocrine neoplasms Indian Journal of Medical and Paediatric Oncology. 41: 166. DOI: 10.4103/ijmpo.ijmpo_165_19 |
0.029 |
|
| 2004 |
Basu S. Financial fragility: Is it rooted in the development process? An examination with special reference to the South Korean experience Neo-Liberal Economic Policy: Critical Essays. 38-70. DOI: 10.4337/9781845423322.00010 |
0.029 |
|
| 1981 |
Basu S. Some characteristics of the occupation structure of the Lower Damodar Valley region ( India) Geographical Review of India. 43: 216-225. |
0.029 |
|
| 1972 |
Basu S. Ultraviolet Absorption and Optical Rotatory Dispersion Studies of Deoxyribonucleic Acid and Nucleohistone Zeitschrift Fur Naturforschung - Section B Journal of Chemical Sciences. 27: 1516-1528. PMID 4143995 DOI: 10.1515/znb-1972-1216 |
0.029 |
|
| 1997 |
Basu S. Seismology of the base of the solar convection zone Monthly Notices of the Royal Astronomical Society. 288: 572-584. DOI: 10.1093/Mnras/288.3.572 |
0.029 |
|
| 1990 |
Basu S. On the Synthesis of a Class of 2-D Acausal Lossless Digital Filters Ieee Transactions On Circuits and Systems. 37: 502-518. DOI: 10.1109/31.52752 |
0.029 |
|
| 2004 |
Basu S. MBST as eco-friendly technology in management of industrial effluents with recycling of resources in pulp and paper industries Ippta: Quarterly Journal of Indian Pulp and Paper Technical Association. 16: 29-32. |
0.029 |
|
| 2015 |
Basu S, Bhattacharya A. Ursodeoxycholic acid versus phenobarbital pretreatment prior to hepatobiliary scintigraphy in neonatal cholestasis: is it time for shifting gears towards a practice change? European Journal of Nuclear Medicine and Molecular Imaging. 42: 1160-1. PMID 25687536 DOI: 10.1007/s00259-015-3011-z |
0.028 |
|
| 1995 |
Basu S, Itoh T, Maas SA. Experimental and Numerical Verification of the Cause of Hopf Bifurcation in a Microwave Doubler Ieee Microwave and Guided Wave Letters. 5: 293-295. DOI: 10.1109/75.410402 |
0.028 |
|
| 2004 |
Basu S. Conceptual Design of an Autonomously Assembled Space Telescope (AAST) Proceedings of Spie - the International Society For Optical Engineering. 5166: 98-112. |
0.028 |
|
| 2012 |
Basu S. Studying stars through frequency inversions Asteroseismology: Xxii Canary Islands Winter School of Astrophysics. 87-122. DOI: 10.1017/CBO9781139333696.005 |
0.028 |
|
| 2013 |
Joshi JM, Barve KS, Basu S. Pulmonary nodules with cavitary mass in a flour mill worker. Journal of Postgraduate Medicine. 58: 328-30. PMID 23298939 DOI: 10.4103/0022-3859.105485 |
0.027 |
|
| 1961 |
BASU S. Cancer jaw Journal of the Indian Medical Association. 36: 416. PMID 13687711 |
0.026 |
|
| 1964 |
Basu S. Theory of Solvent Effects on Molecular Electronic Spectra Advances in Quantum Chemistry. 1: 145-169. DOI: 10.1016/S0065-3276(08)60377-9 |
0.026 |
|
| 1992 |
Basu S, Reinsel GC. A note on properties of spatial yule-walker estimators Journal of Statistical Computation and Simulation. 41: 243-255. DOI: 10.1080/00949652208811404 |
0.026 |
|
| 2005 |
Basu S. Political institutions, strategies of governance and forms of resistance in rural market towns of contemporary Bengal: A study of Bolpur Municipality Rethinking Indian Political Institutions. 125-150. DOI: 10.7135/UPO9781843317524.008 |
0.026 |
|
| 1977 |
Basu S. INVESTMENT PERFORMANCE OF COMMON STOCKS IN RELATION TO THEIR PRICE‐EARNINGS RATIOS: A TEST OF THE EFFICIENT MARKET HYPOTHESIS The Journal of Finance. 32: 663-682. DOI: 10.1111/j.1540-6261.1977.tb01979.x |
0.025 |
|
| 1977 |
Basu S. A natural source of fluorescence depolarization in dye-DNA complexes Journal of Theoretical Biology. 67: 459-470. PMID 904325 DOI: 10.1016/0022-5193(77)90049-2 |
0.024 |
|
| 1977 |
Basu S. Molecular organization of DNA in chromosomes Biopolymers. 16: 2315-2328. PMID 912003 DOI: 10.1002/bip.1977.360161016 |
0.024 |
|
| 2007 |
Basu S. Outgoing editorial Ieee Transactions On Circuits and Systems I: Regular Papers. 54: 2585-2589. DOI: 10.1109/TCSI.2007.913246 |
0.024 |
|
| 2010 |
Basu S. Architectural innovation and SAIL’s strategic response Towards the Next Orbit: a Corporate Odyssey. 155-178. DOI: 10.4135/9788132106760.n9 |
0.024 |
|
| 1990 |
Basu S. Clay mineralogy and pressure analysis from seismic information in Krishna-Godavari Basin, India Geophysics. 55: 1447-1454. |
0.024 |
|
| 2002 |
Basu S. What does helioseismology tell us about solar cycle related structural changes in the sun? European Space Agency, (Special Publication) Esa Sp. 7-14. |
0.024 |
|
| 2014 |
Basu S. 'But What's the Use? They Don't Wear Breeches!': Montaigne and the pedagogy of humor Educational Philosophy and Theory. 46: 187-199. DOI: 10.1080/00131857.2012.721730 |
0.024 |
|
| 2007 |
Basu S. "A little discourse Pro & Con": Levelling laughter and its Puritan criticism International Review of Social History. 52: 95-113. DOI: 10.1017/S0020859007003148 |
0.024 |
|
| 1971 |
Basu S. Binding and interaction of acridine orange with intraphage DNA Bba Section Nucleic Acids and Protein Synthesis. 254: 48-59. PMID 5134207 DOI: 10.1016/0005-2787(71)90113-4 |
0.024 |
|
| 1973 |
Basu S. The electroscope in aid of biology Indian Journal of Radiology. 27: 78-89. |
0.023 |
|
| 1992 |
Basu S. Health and culture among the underprivileged groups Health For the Millions. 18: 23-24. PMID 12343649 |
0.023 |
|
| 2000 |
Basu S. Dimensions of tribal health in India Health and Population: Perspectives and Issues. 23: 61-70. |
0.023 |
|
| 2001 |
Basu S. Disorder effects upon the two-magnon Raman scattering spectrum in a hubbard antiferromagnet Physica Status Solidi (B) Basic Research. 225: 379-392. DOI: 10.1002/1521-3951(200106)225:2<379::AID-PSSB379>3.0.CO;2-W |
0.023 |
|
| 2002 |
Basu S. Approach to a case of hypercoagulable state Journal of Internal Medicine of India. 5: 124-127. |
0.023 |
|
| 1954 |
Basu S. Nitrogen Electronegativity Correction in Free Electron Network Theory Journal of Chemical Physics. 22: 1625. DOI: 10.1063/1.1740492 |
0.022 |
|
| 1973 |
Basu S. Theory of linear dichroism of DNA and DNA-containing structures Journal of Theoretical Biology. 42: 419-441. PMID 4766747 DOI: 10.1016/0022-5193(73)90239-7 |
0.022 |
|
| 1955 |
Basu S. Free-electron treatment of Diels-Alder's reaction The Journal of Chemical Physics. 23: 1548-1549. |
0.022 |
|
| 2010 |
Basu S. Journal of New England Water Environment Association: Letter fro the editor Journal of New England Water Environment Association. 44: 5. |
0.021 |
|
| 1956 |
Basu S. Quantum-mechanical calculation on the oxidation-reduction potentials of quinones Transactions of the Faraday Society. 52: 6-9. |
0.021 |
|
| 2011 |
Basu S. Journal of New England Water Environment Association: Letter from the editor Journal of New England Water Environment Association. 45: 7. |
0.021 |
|
| 2010 |
Basu S. Journal of New England Water Environment Association: Letter from the editor Journal of New England Water Environment Association. 44: 5. |
0.021 |
|
| 1980 |
Basu S. Some structural studies on degraded spondias dulcis gum Carbohydrate Research. 81: 200-201. DOI: 10.1016/S0008-6215(00)85691-8 |
0.021 |
|
| 1985 |
Basu S. Segmentation of wet elongated mitochondria into spheres Progress in Clinical and Biological Research. 196: 313-325. PMID 3909163 |
0.02 |
|
| Hide low-probability matches. |